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ABSTRACT 
ABSTRACT 
Bovine brucellosis is an endemic infectious disease which can negatively impact on 
cattle productivity and welfare as well as on human health. In many developing countries such 
as Ivory Coast, there is a need for knowledge on the distribution and the frequency of the 
disease (or evidence of its presence) within the animal population and the possible factors 
associated with the disease. Information is also needed on species and biovars of Brucella at 
national and regional scales, on the performance of commonly used diagnostic tests for 
accurate estimation of the true disease prevalence, and on determination of risk factors 
associated with the disease. These informations are of key importance to set up and 
implement appropriate and efficient prevention and control measures against brucellosis. For 
these reasons, the research presented in this thesis aimed to contribute to a better 
understanding of the epidemiology of bovine brucellosis in Ivory Coast.  
The thesis is structured into three main parts. The introduction part includes three 
chapters. The first chapter presents an overview of the literature on the pathogen causing 
brucellosis, their characteristics and distribution. The impact and the existing strategies for 
preventing and controlling brucellosis are discussed with a particular reference to the situation 
of bovine brucellosis in Ivory Coast. The presence and the importance of the disease were 
confirmed in the country but the disease is still uncontrolled. In the second chapter (Chapter 
2), an insight on statistical, epidemiological principles and concepts applied to achieve the 
different objectives (Chapter 3) is given, including a discussion on available approaches to 
estimate diagnostic test characteristics and the true prevalence of a disease.  
The second part of the thesis includes research on different aspects of the epidemiology 
of bovine brucellosis in Ivory Coast and West Africa (Chapter 4, 5, 6 and 7). Chapter 4 
specifically provides a state-of–the-art knowledge on species and biovars of Brucella reported 
in cattle from Ivory Coast and all other countries of West Africa, through a review of 
available literature. From the synthesized literature, Brucella abortus was demonstrated to be 
the most prevalent species in cattle in West Africa, in line with the known host preference for 
Brucellae. So far, biovars 3 appeared to be commonly the most isolated in West Africa and 
was also recently identified in Ivory Coast. However, the presence of B. melitensis and/or B. 
suis was not reported yet in cattle in this part of Africa.  
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Results on prevailing strains of Brucella in cattle were related with commonly used 
serological diagnostic tools. Thus, chapter 5 was dedicated to verify their appropriateness and 
to assess the performance of two serological tests, Rose Bengal Test (RBT) and indirect 
Enzyme-linked Immunosorbent assay (iELISA). Using a Bayesian approach, the correlation-
adjusted sensitivity of iELISA was estimated at 96.1 % (Credibility Interval (CrI): 92.7-99.8) 
whereas that of RBT was 54.9 % (CrI: 23.5-95.1). High correlation-adjusted specificities were 
found for both tests, 95.0 % (CrI: 91.1-99.6) for iELISA and 97.7 % (CrI: 95.3-99.4) for RBT, 
respectively. The true prevalence of brucellosis was also estimated using the 1228 tested 
serum samples to be 4.6 with a 95% credibility interval ranging from 0.6 to 9.5% (Chapter 5 
and 6). These results also revealed a good performance for the iELISA, which might 
consequently be a valuable screening assay under the epidemiological conditions prevailing in 
Ivory Coast. 
In Chapter 7, risk factors associated with bovine brucellosis seropositivity were 
investigated using serological results obtained from 907 serum samples collected from 
unvaccinated cattle of at least 6 months of age in the savannah-forest region of Ivory Coast. 
Serum samples were tested using the Rose Bengal test (RBT) and indirect enzyme linked 
immunosorbent assay (iELISA). The logistic regression analysis indicated that brucellosis 
seropositivity was associated with age and herd size. Cattle above 5 years of age were found 
to be more likely seropositive (Odd Ratio (OR) =2.8; 95% Confidence Interval (CI): 1.3, 6.4) 
compared to cattle under 3 years of age. Similarly, the odds of brucellosis seropositivity for 
herds with more than 100 cattle was 3.3 (95% CI: 1.2, 8.9) times higher compared to those 
with less than 50 cattle. 
The third part presents a general discussion on the overall contribution of the current research 
(Chapter 8), by highlighting the main results and pointing out their significance. The need for 
more investigations on the epidemiology of brucellosis, in Ivory Coast and at West African 
scale, is highlighted. It is neccessary to provide additional knowledge on prevailing field 
strains of Brucella, on the distribution of the disease and on associated risk factors to 
implement preventive and control measures. Finally, for more cost-effectiveness and 
efficiency, the need to strengthen the capabilities of the veterinary services and national 
laboratories and to consider the control of brucellosis and other zoonotic diseases through a 
regional, integrated and collaborative perspective is also highlighted.   
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RESUME 
La brucellose bovine est une maladie infectieuse endémique qui peut impacter 
négativement la productivité et le bien-être des bovins ainsi que sur la santé humaine. Dans de 
nombreux pays en voie de développement tels que la Côte d'Ivoire, les connaissances sur la 
distribution et la fréquence de la maladie (ou les preuves de sa présence) dans la population 
animale ainsi que sur les facteurs de risque associés à la maladie restent limitées. La 
disponibilité d’informations sur les espèces et biovars de Brucella à l'échelle nationale et/ou 
régionale, sur la performance des tests de diagnostic communément utilisés pour déterminer la 
prévalence réelle de la maladie, et sur les facteurs de risque est également essentielle. Toutes 
ces informations sont d'une importance clé pour la définition et la mise en œuvre de mesures 
de prévention et de contrôle appropriées et efficaces contre la brucellose.  
Cette thèse vise donc à contribuer à une meilleure connaissance et compréhension de 
l'épidémiologie de la brucellose bovine en Côte d'Ivoire. Elle est organisée en trois parties 
principales. La partie introductive comprend trois chapitres. Le premier chapitre présente une 
revue de la littérature sur les agents pathogènes responsables de la brucellose, sur leurs 
caractéristiques et sur leur distribution. L'impact ainsi que les stratégies existantes de 
prévention et de contrôle de la brucellose sont également discutés avec des références à la 
situation particulière de la brucellose bovine en Côte d'Ivoire. La présence et l'importance de 
la maladie ont été confirmées dans ce pays, mais elle y reste toujours incontrôlée. Le 
deuxième chapitre (Chapitre 2) comprend un aperçu des principes et concepts 
épidémiologiques et des statistiques appliqués dans le cadre de cette thèse pour atteindre les 
différents objectifs présentés au chapitre trois (chapitre 3). Les différentes approches 
méthodologiques disponibles pour l'estimation des caractéristiques des tests de diagnostic 
ainsi que de la prévalence réelle d'une maladie sont aussi discutées.  
La deuxième partie de cette thèse présente, dans un enchainement logique, les 
recherches effectuées sur différents aspects de l'épidémiologie de la brucellose bovine en Côte 
d'Ivoire, avec des références à la situation en Afrique de l'Ouest (Chapitre 4, 5, 6 et 7). Le 
chapitre 4 présente, à travers une revue de la littérature disponible, un état des lieux des 
connaissances sur les espèces et biovars de Brucella signalés chez les bovins de Côte d'Ivoire 
mais aussi chez ceux de tous les autres pays de l'Afrique de l'Ouest. Il en ressort que Brucella 
abortus a été l’espèce la plus répandue chez les bovins en Afrique de l'Ouest, en conformité 
avec la préférence d’hôte connue pour les Brucella. A ce jour, le biovar 3 semble être le plus 
généralement isolé dans les pays d’Afrique de l'Ouest y compris en Côte d'Ivoire où il a été 
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récemment identifié pour la première fois. Cependant, la présence de B. melitensis et/ou de B. 
suis n'a pas encore été signalée chez les bovins dans cette partie de l'Afrique.  
Les résultats sur les souches dominantes de Brucella chez les bovins ont été mis en 
relation avec des outils de diagnostic sérologique couramment utilisés. Ainsi, le chapitre 5 a 
été consacré à vérifier leur pertinence et à évaluer la performance de deux tests sérologiques, 
le test de Rose Bengale (TRB) et l’ELISA indirect (iELISA). En utilisant une approche 
bayésienne, la sensibilité de iELISA ajusté en prenant en compte la corrélation entre les deux 
tests, a été estimée à 96,1% (intervalle de crédibilité (ICr): 92,7-99,8), tandis que celle de 
TRB était de 54,9% (ICr: 23,5-95,1). De hautes valeurs de spécificités ont été trouvées pour 
les deux tests, respectivement 95,0% (ICr: 91,1-99,6) pour l’iELISA et 97,7% (ICr: 95,3- 
99,4) pour le TRB. La prévalence réelle de la brucellose a également été estimée à 4,6% avec 
un intervalle de crédibilté à 95% entre 0,6 et 9,5% sur la base de 1228 sérums analysés 
(Chapitres 5 et 6). Ces résultats ont mis en évidence une bonne performance pour l’iELISA, 
qui pourrait être par conséquent un test de dépistage précieux dans les conditions 
épidémiologiques de la Côte d'Ivoire.  
Dans le chapitre 7, les facteurs de risque associés à la séropositivité de brucellose 
bovine ont été étudiés sur base des résultats sérologiques obtenus de 907 échantillons de 
sérum prélevés chez des bovins non vaccinés d'au moins 6 mois dans la région intermédiaire 
entre la savane et la forêt, au centre de la Côte d'Ivoire. Les sérums ont été testés en utilisant 
le TRB et l’iELISA. L'analyse de régression logistique a indiqué que la séropositivité de la 
brucellose était associée à l'âge des animaux et à la taille du troupeau d’origine. Les bovins de 
plus de 5 ans présentaient une plus grande probabilité d'être séropositif (Odd Ratio (OR) = 
2,8 (Intervalle de confiance (IC) 95%: 1,3-6,4)) par rapport ceux de moins de 3 ans. De 
même, la côte de séropositivité à la brucellose pour les troupeaux de plus de 100 bovins était 
3,3 (IC 95%: 1,2-8,9) fois plus élevée par rapport à ceux de moins de 50 bovins.  
La troisième partie de cette thèse présente une discussion générale sur la contribution 
globale de cette recherche (Chapitre 8). La nécessité d’entreprendre plus d’études sur 
l'épidémiologie de la brucellose, en Côte d'Ivoire et en Afrique de l'Ouest, a été soulignée.  Il 
est nécessaire de fournir des connaissances supplémentaires sur les souches circulantes de 
Brucella, sur la distribution de la maladie et sur les facteurs de risque associés pour la prise de 
mesures de prévention et de contrôle appropriés. Enfin, pour un meilleur rapport coût-
efficacité, il est également nécessaire de renforcer les capacités des services vétérinaires et des 
laboratoires nationaux et d’appréhender la lutte contre la brucellose et les autres maladies 
zoonotiques dans une perspective régionale, intégrée et concertée.  
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RESUMEN 
La brucelosis bovina es una enfermedad infecciosa endémica que puede tener un 
impacto negativo en la productividad y en el bien estar de los bovinos, así como en la salud 
humana. En varios países en vías de desarrollo, como Costa de Marfil, son limitados el 
conocimiento sobre la distribución y la frecuencia de la enfermedad, pruebas de su presencia, 
en la población animal así como los factores de riesgo asociados. Son igualmente necesarios 
los conocimientos en las especies y biotipos de Brucella en el país y en la región, la 
validación de las pruebas de diagnóstico comúnmente utilizadas, y los factores de riesgo. 
Estas informaciones son de gran relevancia para la puesta en marcha de medidas de 
prevención o y para el control adecuado y eficaz contra la brucelosis. 
Esta tesis contribuye a mejorar el conocimiento y comprensión de la epidemiología de 
la brucelosis bovina en Costa de Marfil. Está estructurada en tres partes principales. La parte 
introductoria comprende tres capítulos. El primer capítulo presenta un acercamiento a la 
literatura sobre los agentes patógenos responsables de la brucelosis, sus características y su 
distribución. Se discute el impacto y las estrategias existentes para prevenir y combatir la 
brucelosis con referencias a la situación particular de la brucelosis bovina en Costa de Marfil. 
La presencia y la importancia de la enfermedad han sido confirmadas en dicho país, sin 
embargo, la enfermedad es aún incontrolada. En el segundo capítulo, capítulo dos, se muestra 
los principios y conceptos epidemiológicos y estadísticos aplicados en el marco de la presente 
tesis para lograr los diferentes objetivos, visto en el capítulo tres. Son también discutidos las 
diferentes aproximaciones metodológicas disponibles para la estimación de las características 
de las pruebas de diagnóstico, así como, de la prevalencia real de una enfermedad. 
Basados en investigaciones realizadas, la segunda parte de esta tesis relaciona diferentes 
aspectos epidemiológicos de la brucelosis bovina en Costa de Marfil y en África del Oeste, 
presente en los capítulos cuatro, cinco, seis y siete. El capítulo cuatro muestra el estado 
serológico de los biotipos de Brucella en los bovinos de Costa de Marfil, y de varios países de 
África del Oeste a través de la literatura disponible. Así, la Brucella abortus demostró ser la 
especie más extendida en los bovinos de África del Oeste, de acuerdo a la preferencia de 
hospedador conocido por la Brucella. Actualmente, el biotipo 3 es el más aislado en los países 
de África del Oeste, incluyendo a Costa de Marfil, país confirmado por primera vez. Sin 
embargo, la presencia de Brucella melitensis o/y Brucella suis no ha sido aún encontrada en 
los bovinos de esta parte de África.  
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Los resultados de las cepas de Brucella de los bovinos se relacionaron con las 
herramientas de diagnóstico serológico comúnmente usadas. De esa manera, el capítulo cinco 
verifica su pertinencia y evalúa su desempeño en dos pruebas serológicas, la prueba de Rosa 
de Bengala (RBT) y la de ELISA indirecto (iELISA). Haciendo uso de un enfoque bayesiano, 
la sensibilidad de iELISA ajustada a la correlación entre dos pruebas, fue de 96,1% (Interval 
de credibilidad (ICr): 92,7-99,8), mientras que aquella para RBT fue 54,9% (ICr: 23,5-95,1). 
Así mismo, fueron encontrados fuertes valores de especificidad para las dos pruebas, siendo 
para iELISA de 95,0% (ICr: 91,1-99,6) y para RBT de 97,7% (ICr; 95,3-99,4). A partir de los 
1228 sueros ensayados, la prevalencia real de la brucelosis fue estimada a 4,6% con un 
interval de credibilidad de 95% entre el 0,6 y el 9,5% (Capítulo cinco y seis). Estos 
resusltados muestran el buen desempeño de la prueba iELISA para ser usado en las pruebas 
de despistaje epidemiológico en Costa de Marfil.   
En el capítulo 7, son evaluados los factores de riesgo asociados con la seropositividad 
de brucelosis bovina mediante resultados serológicos obtenidos a partir de 907 muestras de 
suero tomadas de bovinos no vacunados de por lo menos 6 meses de edad en la región límite 
entre  la sabana y la selva, en el centro de Costa de Marfil. Las muestras de suero se 
analizaron mediante la prueba RBT e iELISA. El análisis de regresión logística indicó que la 
seropositividad de la brucelosis se asoció con la edad del animal y el tamaño del rebaño. Los 
bovinos de más de cinco años presentan 2,8 veces más de riesgo (Interval de confidencia (IC) 
95%: 1,3 - 6,4), que aquellos de más de tres años de edad. Por otro lado, el riesgo para la 
brucelosis en hatos de más de cien cabezas de ganado es de 3,3 veces mayor (IC 95%: 1,2 - 
8,9) que aquellos con menos de 50 vacas. 
 La tercera parte, vista en el capítulo ocho de la presente tesis, muestra una discusión 
general sobre la contribución global de la investigación actual poniendo en evidencia los 
principales resultados y señalando su importancia. En tal sentido, se hacen necesarios 
mayores trabajos epidemiológicos sobre la brucelosis tanto en Costa de Marfil como en África 
del Oeste, a fin de proveer conocimientos adicionales y suficientes relativos al origien de la 
Brucella circulante, la distribución de la enfermedad y los factores de riesgo asociados 
orientados a las medidas de prevención o y de control. Para una mejor relación entre el costo 
y la eficacia, se hace necesaria fortalecer las capacidades de los servicios veterinarios y de los 
laboratorios nacionales, así como, de concebir la lucha contra la brucelosis y las otras 
zoonosis sobre una perspectiva regional, integrada y colaborativa.  
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The majority of the world’s poor population (about 75%) works and lives in rural areas. 
About 600 million of the 1.3 billion of the poor worldwide keep livestock as means to 
produce food and generate cash income (IFAD, 2001; Thornton et al., 2002; ILRI, 2012). 
Hence, livestock is of key importance in people's everyday lives in most of the sub-Saharan 
African countries where a quarter of the world’s poor come from (Figure 1). Livestock 
contributes to their financial security, their food security and to the development of their 
agriculture through animal traction and manure (Starkey, 2010; FAO, 2011). The 
development of livestock production and its productivity are therefore part of the solution for 
food security and poverty alleviation, especially in low-income areas. Consequently, there is 
a need to tackle the different constraints to this development, especially the pathological 
ones.  
With its negative impact on animal health and productivity, and its threat to human 
health, brucellosis is one of the pathological constrains to be considered. On a global basis, 
this disease is among the thirteen animal diseases and syndromes identified as having a 
significant impact on poor people worldwide and in West Africa (Perry, 2002). Brucellosis is 
a bacterial infectious disease affecting domestic, wild animals and humans (Maurin et al., 
2005). It is one of the most widespread bacterial zoonotic diseases (Corbel, 2006). According 
to the World Health Organization (WHO), about 500,000 new cases of human brucellosis are 
reported annually worldwide (Corbel, 1997, Pappas et al., 2006).  
In animals, brucellosis is responsible for many economic losses because of abortions, 
decrease in production (particularly reduced milk production), newborn mortality, 
reproductive disorders, and costs of intervention. With its impact on productivity, it 
contributes to worsen the deficit of animal protein especially for populations in developing 
countries, where the needs are continuously increasing. In areas where people’s livelihood 
heavily depends on livestock, the impact of brucellosis might also exacerbate poverty 
(Cáceres, 2010). The most common and widespread form of the disease in animals is bovine 
brucellosis (Akakpo and Bornarel, 1987; Corbel, 1997; McDermott and Arimi, 2002; 
Bronvoort et al., 2009). Therefore, it is the main concern in sub-Saharan African countries 
(McDermott and Arimi, 2002) where average prevalence rates ranging between 10.2 and 
25.7% were reported (Mangen et al., 2002). In West Africa, the disease (or evidence of its 
presence) was reported in 12 out of the 14 countries so far (Mangen et al., 2002; Boukary, 
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2013) with higher seroprevalences estimated in Senegal, Togo, Mali, Niger, Burkina Faso 
and Ivory Coast (Mangen et al., 2002). 
In Ivory Coast
1
, the disease is considered as one of the dominant pathologies affecting 
livestock productivity, with negative impact on livestock breeders’ financial security and 
annual income (Angba et al., 1987; Mangen et al., 2002). Located between 3° to 9° 
Longitude West and 5° to 11° Latitude North, Ivory Coast is a West African country of 322 
462 kilometers of square (Km²) (Annex 1). It is surrounded by Mali and Burkina Faso in the 
North, Ghana in the East and Guinea and Liberia in the West (Figure 2). Its population is 
about 21 millions of inhabitants, of which almost a half live in rural areas (FAO, 2014a). 
Three main agro-ecological areas are encountered (Figure 3): The Guinean zone or forest 
area, in the south, is the most humid and covers almost the whole forest region with annual 
rainfall generally above 1,500 mm. The Soudano-Guinean zone (or savannah-forest area) is 
an area of transition between the forest zone and the north. In this area, annual rainfall varies 
between 1,200 and 1,500 mm. The Soudanean zone in the northern part of the country is the 
savannah region with rainfall ranging between 900 and 1,200 mm per year. According to the 
FAO, there are about 1.6 millions cattle, 3.3 millions small ruminants, and almost 353,000 
pigs (FAO, 2014b). Most cattle herds are concentrated in the northern and central part of the 
country, which is more favorable for livestock breeding with around 85% of the country’s 
cattle population. These cattle are of four different breeds: The N’Dama, the Baoulé, and the 
Lagunaire which belongs to the humpless Bos taurus type and the Zebus of the humped Bos 
indicus type. There are also various crossbred animals (Bos taurus X Bos indicus). 
Conversely to B. Taurus breeds which are mostly raised in the sedentary system, Zebus and 
their crossbred are mostly associated with the transhumance
2
 or semi-transhumance system, 
with movement of cattle toward the central part or within the northern and central part of the 
countries. The extensive system is the dominant type of farming in the country.  
                                                 
 
1
 The official name of the country is “Côte d’Ivoire”, but it is popularly named “Ivory Coast” in 
english. “Ivory Coast” will be used throughout this manuscript.  
2
 Transhumance is defined as an oscillating, seasonal movement of livestock under the care of 
herders, following precise routes in order to exploit pastoral resources. It is distinguished from 
nomadism, which is characterised by more random movements and is followed by the herder’s whole 
family (OECD, 2008). There are agreements for transhumance between member countries of the 
Economic Community of West African States (ECOWAS) since 1998 , allowing inter-states animal 
movements (Anomynous, 1998; Anonymous, 2003b) 
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In Ivory Coast, livestock breeding is still a secondary activity compared to agriculture that is 
practiced by 2/3 of the whole population. According to available figures, livestock breeding 
accounts for only 4.5 % of the agricultural Gross Domestic Product (GDP) and 2% of the 
total GDP of the country (Anonymous, 2003a). As a result, the national coverage of needs in 
meat products (59%) and dairy products (18%) is still insufficient (Anonymous, 2003a). 
Therefore, many efforts are required to cover these needs. Meanwhile, the country is 
dependent on imports from neighbouring countries such as Mali and Burkina Faso. To reduce 
the magnitude of this dependence, many initiatives have been undertaken. Institutions, 
projects and programs were promoted for the development of livestock production and 
increased productivity of local breeds through genetic improvement (e.g., Société pour le 
Développement de la Production Animale (SODEPRA), Agence Nationale pour le 
Développement Rural (ANADER), Programme National de Développement Laitier (PNDL) , 
Programme Sectoriel de l’Elevage (PSE), Projet Laitier Sud (PLS) (Anonymous, 1997)). The 
sustainability of these initiatives also implies tackling the numerous animal diseases of food 
producing animals, including the endemic and zoonotic ones such as brucellosis. 
Controlling brucellosis efficiently requires good diagnostic tools and sufficient and 
reliable information on the epidemiology of the disease. Until now, different aspects of the 
disease have been investigated throughout years in Ivory Coast before this research (Gidel et 
al., 1974; Pilo-Moron et al., 1979; Camus, 1980a; Angba et al., 1987; Thys et al., 2005) since 
first evidences of brucellosis were reported in the 1970s (Böhnel, 1971; Pilo-Moron et al., 
1979). However, available information is still scarce or outdated. Therefore, there is a need to 
update information on the epidemiology of brucellosis, especially on its distribution, the 
causes (which Brucella spp. are involved), and the factors favoring the spread of the disease. 
All these preliminary pieces of knowledge are necessary to understand the epidemiology of 
the disease and to elaborate future preventive and control programs for countries facing 
brucellosis in West Africa, including Ivory Coast. It is particularily important to consider the 
regional perspective, knowing the existence of frequent cattle movements between West 
African countries through transhumance or commercial exchanges (Figure 4). 
This thesis aims to improve the current knowledge on the status of brucellosis in Ivory 
Coast and it is structured in three main parts. The introduction part includes three chapters. In 
Chapter 1, an overview is presented on the disease-causing agents of brucellosis, their 
characteristics, and their distribution. In addition, the impact, the prevention and the control 
measures of brucellosis are presented with references to the situation of bovine brucellosis in 
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Ivory Coast. The chapter 2 includes a review of statistical methodological approaches for 
accurate estimation of diagnostic test characteristics and true prevalence of disease. It also 
brings an insight on statistical, epidemiological principles and concepts applied to achieve the 
different objectives of the thesis, presented in Chapter 3. The second part of the thesis 
includes the research contribution to the different aspects of the epidemiology of bovine 
brucellosis in Ivory Coast and West Africa (Chapter 4, 5, 6 and 7). Finally, the last part 
presents a general discussion on the overall contribution of the thesis (Chapter 8).  
 
 
 
 
 
General introduction 
6 
 
 
 
 
 
Figure 1: Map showing the density of poor people keeping livestock in Africa, 2005 
(ILRI, 2012) 
 
 
 
 
 
General introduction 
7 
 
Figure 2: Administrative map of Ivory Coast (Source: 
http://www.nationsonline.org/oneworld/map/cote-dIvoire-administrative-map.htm)  
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Figure 3: Map showing the agro-ecological areas of Ivory Coast 
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Figure 4: Cross-border transhumance routes in West Africa and Central Africa 
(adapted from OECD, 2008) 
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CHAPTER 1: BRUCELLOSIS: ETIOLOGY, IMPORTANCE, PREVENTION AND 
CONTROL WITH SPECIAL REFERENCES TO THE SITUATION OF THE 
DISEASE IN CATTLE IN IVORY COAST  
1.1. Etiological agents of brucellosis 
1.1.1. Brief history on Brucella 
Brucellosis is an ancient disease. References to what is now known as brucellosis are 
argued to exist in the history up to about five century before Jesus Christ, with a description 
of a resembling condition by Hippocrates (Fernando et al., 2003; Cutler et al., 2005). During 
the 17
th 
and 18
th
 centuries, cases of a mysterious undulant fever were recorded in many areas 
all over the Mediterranean region, with different local names (e.g., Mediterranean fever, 
Rock fever, Gibraltar fever, Cyprus fever, Danube fever, Neapolitan fever, Crimean fever, 
Cartagena fever, Barcelonan fever, Corps disease, undulant fever). In 1859, Dr Jeffrey Alan 
Marston, an assistant surgeon of the British royal artillery on duty in the island of Malta, 
contracted a similar illness, also characterized by an undulant fever (Wyatt, 2013). By 
describing his own case, Dr Marston produced the first detailed clinical description of “Malta 
fever”. His illness was later associated with brucellosis, after another army surgeon, Captain 
David Bruce, identified the causal agent of this disease, a small bacterium (designated 
Micrococcus melitensis and later named Brucella melitenis), isolated from the liver of a 
British soldier who died from a similar disease (Bruce, 1887).  
In 1897, about 10 years after the works of Captain Bruce, Prof. Almroth Wright described the 
first serological diagnostic test for the disease, the sero-agglutination tube test. Meanwhile, a 
new bacterium designated Bacillus abortus was isolated from repetitive abortive cows by 
Bernhard Bang, a Danish veterinarian. The first relation between the disease in human and an 
animal source was made about fifty years after the first clinical description, in 1905, by Dr 
Themistocles Zammit who associated the disease in humans with unpasteurized goat milk 
(Zammit, 1905). In 1917, Alice Evans, an American bacteriologist related Bacillus abortus 
and Micrococcus melitensis and the two bacteria were grouped into a single genus designated 
Brucella, as a tribute to Captain David Bruce (Meyer and Show, 1920).  
In sub-saharan Africa, the first references to Malta fever were made in the early 1900s 
in Senegal and Mauritania (Bourret, 1910). However, evidence of the disease in animals 
started to be reported in the 1930s especially in West African countries (Akakpo and 
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Bornarel, 1987). In Ivory Coast, Böhnel (1971) provided the first evidence of the disease in 
cattle during a serological survey in the northern part of the country. Some years later, 
serological evidences in humans were also provided (Gidel et al., 1974). 
1.1.2. Taxonomy, description and characteristics of Brucella  
The etiological agents of brucellosis are bacteria members of the genus Brucella. The 
genus Brucella belongs to the family Brucellaceae within the order Rhizobiales of the class 
Alphaproteobacteria (Meyer and Shaw, 1920; Godfroid et al., 2011). 
Brucellae are facultative intracellular bacteria that grow slowly in aerobic conditions at 37°C 
but some strains may require 5 to 10% carbon dioxide for growth. Phenotypically, Brucellae 
appear as short rods (0.5-0.7 µm×0.6-1.5µm), non-motile, non-capsulate, small Gram-
negative coccobacilli. After three to seven days of incubation on culture plates (Quinn et al., 
1999; Alton et al., 1988), Brucellae colonies appear with round (2-4 mm in diameter), pin-
point shape, smooth, rough or mucoid (intermediate) aspect (Corbel and Brinley-Morgan, 
1984). Contrarly to rough strains, smooth strains contain an O antigen on the 
lipopolysaccharide (LPS), a structural component of the outer membrane of the bacteria and 
appear translucent with a honey-color (Figure 5). Among the known species, so far, only B. 
canis and B. ovis have a rough shape (Alton et al., 1988).  
 
 
Figure 5 : Brucella colonies on a solid culture media, showing translucent honey-colored 
appearance (credit picture: M. Sanogo) 
 Using bacteriological examination, complete identification of Brucella until biovar 
level is made with a combination of morphological, cultural and biochemical characteristics 
(Table I). Classification of Brucella into species is dependent on criteria as natural host 
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preference, sensitivity to Brucella phages (Tbilisi (Tb), Weybridge (Wb), BK2, R/C) and 
oxidative metabolic profiles. Requirement of CO2 on primary isolation, H2S production, 
sensitivity to inhibition by thionin, basic fuchsin and safranin O dyes, and agglutination 
response to monospecific antisera for the A antigen of B. abortus and for the M antigen of B. 
melitensis M are used to determine subtypes or biovars (Corbel and Morgan, 1975; Alton et 
al., 1988; Saegerman et al., 2010; Godfroid et al., 2010). Nevertheless, the classification into 
subtypes or biovars may be sometimes problematic due to variability of some of the 
characteristics used for typing, such as sensitivity to dyes (thionine, fuschine, and safranine 
O), H2S production and CO2 requirement for growth (Acha and Zysfres, 2003). When they 
are available, DNA-based methods are also useful tools to characterize the different species 
and biovars of Brucella. They are particularly useful when a high discrimative power is 
needed and can be used in combination with other identification and typing methods (Adone 
et al., 2001; Bricker, 2002; Bricker et al., 2003). Various methods have been developed over 
the time including the Multilocus sequence analysis (MLSA), the whole genome sequencing 
and the global genome-wide Single nucleotide polymorphism (SNP) analysis (Le Flèche et 
al., 2006; Yu and Nielsen, 2010; Bankole et al., 2010; Sanogo et al., 2013a, Jiang et al., 
2013; Scholz and Vergnaud, 2013). In addition to their high resolution, molecular based 
methods limit the manipulation of living agent (Le Flèche et al., 2006). 
Traditionally, species of Brucellae are determined according to their host preference 
and pathogenicity. Thus, the different species of Brucella and their associated hosts are as 
follows: B. abortus (cattle), B. melitensis (goats), B. suis (swine), B. canis (dogs), B. ovis 
(sheep), and B. neotomae (rodent) (Godfroid et al., 2005; Corbel, 2006; Saegerman et al., 
2010). In addition to these common species, new strains of Brucella were later described. B. 
microti were isolated from common vole (Microtus arvalis) and wild red fox (Vulpes vulpes), 
B. pinnipediae and B. ceti in marine mammals (Ewalt et al., 1994; Foster et al., 1996; 
Clavareau et al., 1998; Godfroid et al., 2005; Cutler et al., 2005; Scholz et al., 2008; Scholz 
et al., 2010; Banai and Corbel, 2010; Nymo et al., 2011). Up to date, at least 10 species have 
been reported as members of the genus Brucella (Godfroid et al., 2011; Scholz and 
Vergaund, 2013). A summary of known species until now and a description of the different 
biovars are presented in Table I and Figure 6. Moreover, because of a high phylogenetic 
homogeny, it was suggested to consider all Brucella as belonging to the same single species 
namely B. melitensis and the other species of Brucella becoming the biotypes or biovars 
(Verger et al. 1985, 1987; De Ley et al., 1987; Cutler et al., 2005; Scholz et al., 2008). 
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Despite the scientific accuracy of this homogeny, the suggested classification is still not 
widely adopted due to lack of practicability (Pappas et al., 2005) and because the different 
species are also considered as different ecotypes (Cohan, 2002). Regarding the host 
preference-based classification, even if it appears more convenient, it is now apparent that a 
given host can be infected by different species of Brucella (Cutler et al., 2005). Thus, B. 
melitensis and B. suis were also reported in cattle in some epidemiological contexts, where 
cattle have contact with pigs and where cattle and small ruminants are grazing on common 
pastures as it is the case in Latina America, southern European countries and in the middle 
East (e.g. Godfroid and Kasbohrer, 2002; Godfroid et al., 2005, Szulowski et al., 2013, Fretin 
et al., 2013). The presence of B. melitensis in cattle was also documented in North Africa 
(e.g. Samaha et al., 2008) and in Eastern Africa (e.g. Muendo et al., 2012). In Western 
Africa, the lack of this kind of report did not preclude the possible presence of other species 
of Brucella in cattle population.  
 
Figure 6: Dispersion of Brucella species according to their preferred host mammal. The 
dispersion of the various Brucella species is depicted as cones proportional to the 
number of strains analyzed (adapted from Moreno, 2014).   
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Table I: Nomenclature and characteristics of Brucella species (from Pappas et al., 2005; Whatmore, 2009; Whatmore et al., 2014) 
Species 
Biovar Animal Hosts Human virulence* Species discrimation 
B. melitensis 1-3 Goats, sheep, camels ++++ Fushin, positive; thionine, positive; safranin inhibition, negative; H2S production, 
negative; urease, positive in 24 hr; CO2 growth, negative;Tbilisi phage lysis, 
negative; Weybridge phage lysis, negative 
B. abortus 1-6, 7**, 9 Cows, camels, yaks, buffalo ++ to +++ Fushin, positive (except biovar 2); thionine, negative (Biovar 1,2 and 4); safranin 
inhibition, negative; H2S production, positive (except biovar 5) urease, positive in 
24 hr; CO2 growth, positive (biovar 1-4);Tbilisi phage lysis, positive; Weybridge 
phage lysis, positive 
B. suis  1-5 Pigs (biovars 1-3), wild hares (biovar 2), 
caribou (biovar 4), reindeer (biovar 4), 
rodents (biovar 5) 
+ Fushin, negative (except biovar 3); thionine, positive; safranin inhibition, positive; 
H2S production, positive (biovar 1); urease, positive in 15 min; CO2 growth, 
negative;Tbilisi phage lysis, negative; Weybridge phage lysis, positive 
B. canis - Canines + Fushin, positive or negative; thionine, positive; safranin inhibition, negative;  H2S 
production, negative; urease, positive in 15 min; CO2 growth, negative;Tbilisi phage 
lysis, negative; Weybridge phage lysis, negative 
B. ovis - Sheep - Fushin, negative for some strains;  safranin inhibition, negative;  H2S production, 
negative; urease, negative; CO2 growth, postive;Tbilisi phage lysis, negative; 
Weybridge phage lysis, negative 
B. neotomae - Rodents - Fushin, negative;  safranin inhibition, negative;  H2S production, positive; urease, 
positive in 15 min; CO2 growth, negative;Tbilisi phage lysis, positive or negative; 
Weybridge phage lysis, positive 
B. pinnipidialis and 
B. ceti 
- Minke whales, dolphins, porpoises 
(pinnipediae), seals (cetaceae) 
+ Fushin, positive; thionine positive;  safranin inhibition, negative;  H2S production, 
negative; urease, positive; CO2 growth, negative for B. pinnipidialis and positive for 
B. ceti ;Tbilisi phage lysis, negative; Weybridge phage lysis, positive for B. 
pinnipidialis and negative for B. ceti 
B. inopinata - Unknown but isolated from human ?*** Fushin positive; thionine , positive;  H2S production, positive; urease, positive; CO2 
growth, negative;Tbilisi phage lysis, positive or negative; Firenze phage lysis,  
negative 
B. papionis sp. nov.  - Unknown but isolated from baboon ? Fushin positive; thionine , positive;  H2S production, negative; urease, strongly 
positive; CO2 growth, negative; Tbilissi phage lysis, partially positive; Weybridge 
phage lysis, positive; Berkeley phage lysis, positive; Firenze phage lysis,  positive;  
* Virulence is graded on a scale from no virulence (–) to the highest degree of virulence (++++); **The status of this B. abortus biovar 7 in under review.***Not known 
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1.2. Importance and distribution of brucellosis 
1.2.1. Socio-economic and public health importance  
Brucellosis is an infectious disease with both socio-economic and public health 
importance. When present, the disease may have serious impact on animal production and 
productivity. It may also represent a severe hazard for human health. Brucellosis is also an 
important disease because of its potential to be weaponized for bioterrorism as it was the case 
during the 1950s (Cutler et al., 2012). 
With more than 500,000 new human cases recorded yearly, brucellosis is a major 
bacterial zoonotic disease of global importance (Cutler et al., 2005; Pappas et al., 2006; 
Corbel, 2006). Human brucellosis (or Malta fever or undulant fever) is responsible for an 
acute to chronic or severe debilitating and disabling disease with a wide range of clinical 
signs. These clinical signs include an “undulant” fever, sweating, weakness, headache, 
anorexia, weight loss, pain in joints and generalized pain (McDermott and Arimi, 2002; Dean 
et al., 2012). Human brucellosis is rarely fatal but tends to be chronic if not treated. Thus, 
complications such as endocarditis, meningitis (also called neurobrucellosis) and orchitis may 
occur (Corbel, 2006). The severety of the disease in human depends on the type of Brucella 
involved and the source of infection. Most severe clinical cases are commonly associated 
with B. melitensis (Benkirane, 2001; Corbel, 2006). Data on the actual incidence of the 
disease in humans are scare or lacking especially in sub-Saharan African countries. Available 
data suggest a higher incidence in low to middle-income countries where effective diagnosis 
or treatment is lacking or where programs for detecting and preventing infection in both 
humans and animals are not adequately implemented (Cutler et al., 2005; Corbel, 2006; Dean 
et al., 2012). In developing countries the infection rate was estimated to be above 10% 
(USDA and ILRI, 2013) and in the Republic of Chad, an incidence of 34.8 per 100,000 
person-year was reported in nomadic communities (Dean et al., 2012).  
In animals, brucellosis is also recognized as a major pathological constraint to the 
development of livestock in sub-Saharan African countries (Camus, 1980a; Domenech, 1987; 
Akakpo, 1987). As a major constraint, brucellosis needs to be especially accounted for in 
developing countries, where about 70% of rural poor depend on livestock as part of their 
livelihood (LID, 1998). In addition to its public health importance, brucellosis has a negative 
impact on animal health and productivity. It primarily affects the reproductive system of the 
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host resulting in economic losses on productivity through late term abortions, calf mortality, 
reduced milk production and infertility (Pilo-Moron et al., 1979; Domenech, 1987; Corbel, 
1997). The disease is reported to be responsible for about 20 to 25% of milk yield reduction 
(Timm, 1982; Acha and Szyfres 2005). A prevalence of about 30% infected cows within a 
herd is argued to cause a loss of the herd productivity of about 6 % (Domenech et al., 1982). 
Economic impact of brucellosis may also be indirect through the costs for veterinary 
interventions, investment for prevention and control measures (including vaccination and 
compensation), investment for restocking (in countries where culling is practiced) and losses 
related to consecutive exportation restrictions.  
Despite these known consequences, estimation of the actual economic impact of the 
disease in animal remains difficult. Mangen et al. (2002) estimated the losses of the annual 
value produced per animal between 6 and 10% (Mangen et al., 2002). Similarly, Camus 
(1980) reported a loss of about 10% of the annual income of cattle breeders in Ivory Coast 
due to brucellosis (Camus, 1980a). In Latin America, the annual losses related to bovine 
brucellosis were estimated to approximately 600 million USD
3
 (Acha and Szyfres, 2003). 
Similarly, estimation of the burden of the disease in humans is difficult, but it is expected to 
be high. For an average of 13 days spent in a hospital, Colmenero-Castillo et al. (1989) 
estimated an overall cost of 8,000 USD
4
 for human brucellosis per case in Spain. In addition, 
the total number of work absence days was 102 days per patient (Colmenero-Castillo et al., 
1989). For the case of bioterrorist attack with B. melitensis, the economic impact for 100,000 
persons exposed is expected to be about 478 million USD
5
, related to 82,500 human cases of 
brucellosis requiring extended therapy and leading 413 deaths (Kauffman et al., 1997). 
Therefore, given the serious consequences of brucellosis for public health and the economy, 
the disease needs to be considered carefully, especially in low-income countries such as Ivory 
Coast (McDermott and Arimi, 2002; Mangen et al., 2002; McDermott et al., 1013).  
                                                 
 
3 About 473 millions euros or about 310 billions FCFA  
4
 About 6,308 euros or about 4,138,000 FCFA 
5
 About 377 millions euros or about 248 billions FCFA 
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1.2.2. Distribution of brucellosis 
1.2.2.1. Disease in animals 
Considering the wide range of potential animal hosts, brucellosis is one of the most 
widespread diseases in the world. Since the beginning of the 1900s, animal brucellosis has 
been commonly reported in sub-Saharan countries, where bovine brucellosis remains the 
most widespread form (Akakpo and Bornarel, 1987, Corbel; 1997; Mangen et al., 2002; 
McDermott and Arimi, 2002; Bronvoort et al., 2009). The disease is endemic in most of the 
African countries (Corbel, 1997; Akakpo and Bornarel, 1987) with different prevalences 
(McDermott and Arimi, 2002). An overall apparent seroprevalence rate based on Rose 
Bengal testing was estimated to range from 10.2 to 25.7% in cattle populations of sub-
Saharan Africa (Mangen et al., 2002). In West Africa, evidence of the disease was found in 
all the countries where research was conducted including Benin, Burkina Faso, The Gambia, 
Ghana, Guinea, Ivory Coast, Mali, Niger, Nigeria, Senegal, Sierra Leone and Togo (Mangen 
et al., 2002; Unger et al., 2003). In Ivory Coast, brucellosis is among the dominant 
pathologies affecting cattle population (Angba et al., 1987). Since the first evidences in this 
country, the prevalence of the disease has been investigated throughout the years and at 
different geographical scales. These investigations mainly covered the northern and central 
regions, the main breeding areas of the country (Table II). Results from a national survey 
conducted between 1975 and 1977 reported a seroprevalence in cattle of 11.3% (Angba et al., 
1987). More recently, Thys et al. (2005) estimated a true prevalence of 3.6 and 4.2% 
respectively in dairy farms and their neighbours’ traditional farms in peri-urban area of 
Abidjan (Thys et al., 2005). Recently, using sera collected during the serosurveillance of 
Rinderpest in Ivory Coast, the true prevalence of the disease in traditional cattle was 
estimated to range between 5 and 16% in the central part of the country (Sanogo et al., 2008).  
The different species and biovars of Brucella are distributed heterogenously throughout the 
world but B. abortus remains the most prevalent worldwide so far (Corbel, 1997; Robinson, 
2003; Acha and Szyfres, 2005). The presence of biovars 1 and 6 of B. abortus has also been 
confirmed in Ivory Coast from hygroma fluid samples (Pilo-Moron et al., 1979). No isolates 
of B. melitensis have yet been reported in this country neither in cattle nor in the small 
ruminants, despite evidence of the presence of the disease in small ruminants (Gidel et al., 
1974; Chartier, 1982). 
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Table II: Studies on prevalence of bovine brucellosis in Ivory Coast, 1970-2008 
Author (s), year of 
publication 
Study area Type of herd 
Number of tested  
animals 
Tests applied 
Average infection 
 rate (%) 
Anomynous, 1970 Bouaké  Not  specified 24 BPAT
 a 
 75% (53.3-90.2)
 b
 
Böhnel, 1971 Korhogo  Not specified  554 MRT 11.7% (9.2-14.7) 
Coulibaly, 1973 Bouaké Not specified 281 Not specified 23% (18.3-28.5) 
Gidel et al., 1974 
Korhogo,  Bouaké 
Katiola, Odienné, Man 
Traditional and sedentary 
farms 
1327 MRT 42,9 (23,0-51,0) 
749 SAW and CFT 15,5 (2,6-25,8) 
Pilo-Moron et al., 1979 
Korhogo Bouaké, 
Abengourou 
Abidjan 
Traditional and sedentary 
farms  
12.343 SAW, RBT 10,1 (1,0 -39,3) 
Camus, 1980a 
Korhogo, Boundiali 
Odienné, 
Ferkessédougou, 
Bouna, Touba 
Sedentary herds  1.214 RBT 28,3 (9,1-37,7) 
c 
 
Angba et al., 1987 National survey Not specified Not specified SAW, RBT 11,3 (9,5-14,0) 
Thys et al., 2005
d
 
District of Abidjan 
(Bingerville, Azaguié ) 
Dairy farms 244 
SAW-EDTA 
RBT, CFT, iELISA 
3,6 (1,2-7,1) 
Traditional farms 137 
SAW-EDTA, 
RBT, CFT, iELISA 
4,3 (1,3-8,8) 
Sanogo et al., 2008
 d
 
Bongouanou, Dimbokro, 
Tiébissou, Toumodi, 
Yamoussoukro 
Traditional farms 660 
SAW-EDTA, 
RBT, CFT, iELISA 
8.8 (5.0-16.4) 
a
 The antigen used was a B. melitensis strain  
b 
The prevalence range is presented within brackets  
c 
Only cows were used for this estimation 
d
 Infection rate presented by these authors are true prevalence 
MRT(Milk Ring Test) ; SAW (-EDTA)(Slow Agglutination of Wright(with EDTA) ;RBT(Rose Bengal Test ), CFT(Complement Fixation Test) ; iELISA (indirect ELISA)
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1.2.2.2. Disease in human 
Brucellosis is among the most neglected zoonotic disease in the world (WHO, 2012; 
Mableson et al., 2014). As any other zoonotic diseases, the occurrence of brucellosis in 
human in a given geographical region is related to the infectious status of animals (Godfroid 
et al., 2005; Saegerman et al., 2010). Infection of a given host by Brucella may occur either 
directly via ingestion, via inhalation of infected products or indirectly (Figure 7).  
 
Figure 7: Main transmission routes of brucellosis from livestock to humans (by Sir 
David Bruce, 1855-1931) (from http://m2002.tripod.com/brucellosis.jpg) 
Even if direct or close contact with aborted material or infected animal is required for 
transmission of Brucella, indirect transmission is possible through contaminated pasture, 
vehicles, feed or water (Roop et al., 2003). Most of the time, the transmission of Brucella to 
human mainly occurs via the consumption of raw animal products and direct contact with 
infected animals, aborted tissues and discharges (Marcotty et al., 2009; Saegerman et al., 
2010). Human brucellosis is mainly an occupational disease, affecting people who have 
contact with infected animals or their tissues such as farm workers, veterinarian, ranchers, 
and meat picking employees (OIE, 2009). Therefore, consumers of unpasteurized dairy 
products and hunters who unknowingly handle infected animals may also get brucellosis 
(Ocholi et al., 2004; Arimi et al., 2005). To a lesser extent, sexual transmission was also 
reported (Meltzer et al., 2010) but not confirmed (Ron-Román et al., 2012). So far, human 
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brucellosis is known to be caused by B. melitensis, B. suis, B. abortus and to a lesser extent 
by B. canis (Acha and Szyfres, 2005). A zoonotic potential has also been alleged for newly 
reported strains in marine mammals but further investigations are needed (Godfroid et al., 
2005). Humans are known to be more sensitive to infections caused by B. melitensis and B. 
suis, especially biovars 1 and 3 for the later (Godfroid et al., 2005; Saegerman et al., 2010). 
Brucella abortus infections are relatively low pathogenic and usually develops an insidious 
subclinical form. The incidence of the disease in human is not well known but higher 
prevalences are reported in the Mediterranean region of Africa, Middle East, Latin America 
and Asia (Samartino et al., 2005, Pappas et al., 2006; Aznar et al., 2014) (Figure 8). 
 
Figure 8:  Global Incidence of Human Brucellosis (from Pappas et al., 2006) 
In West Africa, knowledge on the actual impact of the disease in humans remains 
limited (Figure 8). However, even if the actual incidence of the disease is not known, the 
presence of human brucellosis cannot be excluded since brucellosis stays neglected and 
under-reported in many African countries. This might be related to the non-specific clinical 
signs of human brucellosis, which could also be confused with other endemic febrile illness 
such as malaria and typhoid fever (McDermott and Arimi, 2002). Nevertheless, serological 
evidence of the presence of Brucella in humans has already been documented for many 
Western African countries like Benin, Burkina Faso, Ivory Coast, Guinea, Guinea Bissau, 
Mali, Togo and Nigeria (Pappas et al., 2006; Akakpo et al., 2010, Dean et al., 2013). 
Available data on human brucellosis in Ivory Coast are scarce. In the 1970s, serological 
evidence of the presence of the disease in human was reported in northern and central region 
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of the country despite a low infection rate in animals (Gidel et al., 1974). In 1985, brucellosis 
infection in human was estimated to be 6.52 % and 0.45% using respectively the intradermo-
reaction with Brucella melitine as allergen and serology (Angba et al., 1987).  
1.3. Prevention and control of brucellosis 
1.3.1. Diagnostic tools 
Brucellae are facultative intracellular bacteria with a special tropism for the host 
reproductive system and may affect a wide range of hosts including human, domestic and 
wild animals. When transmission occurs, Brucellae initially invade regional lymph nodes. 
Then, after a brief bacteremia, they spread to other tissues and organs of the body, with a 
particular tropism for the reproductive tract (Olsen and Tatum, 2010). This results in an 
increased excretion of Brucellae during parturition particularly in aborted fetal fluid, vaginal 
discharges, placenta and milk. Due to the tropism and their proliferation in the reticulo-
endothelial cells of the reproductive tract, Brucellae induce various clinical signs from birth 
of a viable but weak calf, placenta retention, metritis, subclinical mastitis, reduced milk 
production, infertility, orchitis or epididymitis with or without sterility to late term abortion at 
the first gestation (Acha and Szyfres, 2003). Among these clinical manifestations, abortion is 
the cardinal clinical sign commonly associated with brucellosis (Acha and Szyfres, 2003; 
Godfroid et al., 2010). Joint colonization by Brucella may occur resulting in articular and 
peri-articular hygroma’s. In Africa, the presence of hygroma in a herd is commonly 
associated with brucellosis (Thienpont et al., 1961; Ocholi et al., 2004; Bankole et al., 2010; 
Saegerman et al., 2010). However, none of these clinical signs is specific for brucellosis. 
Therefore, the use of laboratory techniques remains essential to improve the accuracy of the 
diagnosis. Two main types of laboratory techniques could be used for the diagnosis of 
brucellosis: on the one hand, tests which allow a direct detection of the presence of Brucella 
(bacteriology, molecular methods) and on the other hand, tests which detect this presence 
indirectly through detection of the immune response of the host to Brucella antigens (mainly 
serological and intradermic methods).  
Diagnostic tests are useful to determine the disease status at individual level or group of 
individual within a population of interest. They are also crucial for studying the epidemiology 
of the disease, to assess the actual impact of disease (Greiner and Gardner, 2000). Diagnostic 
assays for brucellosis were thoroughly described and reviewed in the OIE manual of 
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diagnostic tests and vaccines for terrestrial animals (OIE, 2009) and by several authors 
(Nielsen, 2002; Saegerman  et al., 2010; Godfroid et al., 2010; Yu and Nielsen, 2010). A 
brief overview of the different methods is presented in the following sections.  
1.3.1.1. Direct diagnostic methods 
1.3.1.1.1. Bacteriological examination 
Morphological, staining and cultural characteristics of Brucella may be used for a direct 
identification of its presence. Despite its lack of specificity, examination of stained smears 
from abortive material or suspicious organs or fluid can provide valuable information. 
However, definitive diagnostic is made by culture (Yu and Nielsen, 2010). According to 
clinical signs, a range of samples is available including fetal membranes, vaginal secretions, 
milk, semen, arthritis or hygroma fluids, lymph nodes, spleen, uterus, udder, testes, 
epididymes, joint exudates, abscesses and other tissues of infected cattle. The stomach 
content, spleen and lungs of aborted fetuses may also be used for bacteriological examination 
(Alton et al., 1988; Corbel, 2006, OIE, 2009; Godfroid et al., 2010). In case of abortion 
caused by brucellosis, concentrations of Brucella in fetal fluids or placenta may reach 10
9
 to 
10
10
 colony-forming units (CFUs)/g compared to an estimated minimum infectious dose of 
10
3
 to 10
4
 CFU (Olsen and Tatum, 2010; Saegerman et al., 2010). Brucellae may also be 
spread from infected udders and supramammary lymph nodes into milk at concentrations 
going from a few hundred up to 2x10
6
 organisms/ml of milk (Corbel, 1988). Therefore milk, 
mammary glands and associated lymph nodes can be used as samples (Xavier et al., 2009; 
O’Grady et al., 2014). In Africa, the use of hygroma fluid as sample for Brucella isolation 
and identification is common (Ocholi et al., 2004; OIE, 2009; Bankole et al., 2010). Isolation 
of Brucella is considered as the “gold standard” reference test to determine the status of the 
animal regarding brucellosis (Godfroid et al., 2010; Yu and Nielsen, 2010). Nevertheless, 
implementation of bacteriological methods is laborious, time consuming, costly and requires 
enhanced biosafety and biosecurity measures. The risk for human health implies that 
handling of Brucella be done careful and restricted to laboratories with appropriate 
containment facilities like biosafety level 3 (BSL3) laboratories (OIE, 2009). Thus, despite 
their usefulness for the detection of Brucella, the implementation of these methods is limited 
in developing countries. The main different characteristics used to differentiate among 
Brucella species using bacteriological examination are summarized in Table III.  
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Table III: Characteristics for differentiating the different Brucella (from OIE, 2009) 
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1.3.1.1.2. Molecular methods 
Compared to bacteriological methods, molecular based methods to detect Brucella are 
considered less fastidious, less time consuming and with reduced risk of manipulation. Even 
if detection of antibodies produced against Brucella is indicative of the presence of 
brucellosis, identification and typing of the disease-causing agents provides the ultimate 
evidence of the actual presence of the disease (Nielsen, 2002). Molecular methods are based 
on the detection of Brucella DNA and therefore provide actual evidence of the latter (Yu and 
Nielsen, 2010). Since 1987, many Polymerase Chain Reaction (PCR) based methods were 
developed throughout the years for the diagnosis and identification of Brucella (Bricker and 
Halling, 1994; Bricker, 2002; Whatemore, 2009; Yu and Nielsen, 2010; Godfroid et al., 
2011, Scholz and Vergnaud, 2013). It includes i.e., Abortus-Melitensis-Ovis-Suis (AMOS) 
PCR, conventional multiplex PCR, single nucleotide polymorphism (SNP) analysis and 
multilocus sequence typing (MLST) or multilocus sequence analysis (MLSA) . They can be 
used either for diagnostic purposes or for biotyping. Molecular methods are useful and 
convenient to characterize circulating biovars of Brucella and for epidemiological 
investigations particularly when a higher discriminatory power is needed (Bricker et al., 
2003; Cutler et al., 2005; Le Flèche et al., 2006). Molecular methods can also be used as a 
complementary test for other tests (Adone et al., 2001; Bricker, 2002). Yu and Nielsen (2010) 
published a broad overview on molecular methods for detection of Brucella, including highly 
discriminative methods such as Multiple loci Variable number tandem repeats Analysis 
(MLVA). More discriminative molecular methods are under development with recently 
available methods like the whole genome sequencing (WGS) and the global genome-wide 
Single Nucleotide Polymorphism (SNP) analysis. 
1.3.1.1.3. Maldi-TOF Mass Spectrometry (MALDI-TOF-MS) 
The Matrix-assisted laser desorption/ionization time-offlight mass spectrometry 
(MALDI-TOF-MS) is recognized as a reliable method for identification of Brucella at genus 
level from culture plates samples and directly from blood culture bottles (Ferreira et al., 
2010; Lista et al., 2011, Kasymbekov et al., 2013). It is considered as a fast, cost-effective 
and accurate method, which is suitable for the high-throughput identification of bacteria by 
less-skilled laboratory personnel (Seng et al., 2009). Identification of bacteria is done by 
comparing the obtained MS spectra to the MS spectra or profiles from a reference library, 
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which constitutes the main limiting factor of the enhanced identification of Brucella using 
this method so far (Lista et al., 2011). 
1.3.1.2. Indirect diagnostic methods 
1.3.1.2.1. Serological methods 
When a host is exposed to Brucella, the immune system induces the production of 
different types of immunoglobulins (Ig) regardless the Brucella species. This immune 
response is induced by the presence of surface lipopolysaccharides (LPS) on the outer cell 
membrane of Brucella, which contains the O chain, the immunodominant antigen
6
 (Alton et 
al., 1988). In cattle, the first antibody response is the production of IgM at a larger (or less) 
and persistent amount (2-3 weeks post-exposure) according to the dose of bacteria, the route 
of infection and the status of the animal infected. However, IgM may disappear after a few 
months (Godfroid et al., 2002; Saegerman et al., 2004; Godfroid et al., 2010). Then, the 
production of IgG1 arrives very shortly after the IgM, followed later by IgG2 and IgA 
(Nielsen, 2002; Yu and Nielsen, 2010). The presence of these different antibodies can 
therefore be useful to evidence of the presence of Brucella and serological diagnostic tools 
can be use to detect them. Compared to bacteriological examination, detection of antibodies 
appears to be a more convenient approach for the diagnosis of brucellosis, since they are less 
fastidious, easier to implement and more suitable for large-scale investigation. 
Because the immunodominant epitope on the Brucella LPS is the basis of the 
serodiagnosis of brucellosis, most of the conventional serological tests may suffer from some 
limitations since the immunodominant antigen is also present in many other Gram-negative 
bacteria. Like Brucella, these bacteria induce the production of identical antibodies resulting 
in cross-reactions or false positive serological reactions (FPSR) when testing. These false 
positive serological reactions (FPSR) were reported with Gram-negative bacteria such as 
(e.g.) Yersinia enterocolitica O: 9, Escherichia coli O: 157, Francisella tularensis, 
                                                 
 
6
 The immunodominant O-polysaccharide (OPS) which has been chemically defined as a 
homopolymer of 4,6-dideoxy-4-formamide-alpha-D-mannose linked via glycosidic linkages is 
common in Smooth Brucella strains but is lacking in Rough strains (i.e., B. ovis and B. canis). As a 
result, B. abortus antigen in the form of whole cells, SLPS or OPS is used as antigen for serological 
detection of the smooth strains while RLPS is commonly used as the main antigen for detection of 
antibody for the latters (Yu and Nielsen, 2010).  
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Salmonella urbana O: 30, Vibrio cholera. The presence of possible FPSR bacteria become an 
important issue especially in free brucellosis areas, countries with low incidence or in the last 
stages of an eradication program (Saegerman et al., 2004; Munoz et al., 2005; Cutler et al., 
2005; Corbel, 2006; Yu and Nielsen, 2010). In addition, vaccination with strain S19 (also 
named B19) may also cause interference in serological reactions. Consequently, the 
application of serological tests has to be related with the incidence of the disease and 
vaccination status in order to prevent misinterpretation (Corbel, 2006). The use of a given 
serological test for the diagnosis of brucellosis should therefore take into account of the 
epidemiological context (Robinson, 2003). A description of the different types of antibodies 
detected by the different serological assays is presented in Table IV. Different serological 
methods for the diagnosis of brucellosis have been developed over the years. These include 
the agglutination tests, complement fixation tests, primary binding tests and hypersensitivity 
tests (Nielsen, 2002, Cutler et al., 2005).  
Table IV: Types of antibodies detected by conventional serological assays for the 
diagnostic of brucellosis (from Quinn et al., 1999 and Saegerman, 2004) 
Type of 
Sample  
Tests 
Type of antibodies 
IgM IgA IgG1 IgG2 
Blood SAW (with EDTA) + - ± + 
RBPT + - + - 
CFT + - + - 
iELISA
a
 - - + + 
Milk  MRT + + ± ± 
iELISA - - + + 
+/-/± : serological response ; MRT (Milk Ring Test) ; SAW (-EDTA)(Slow agglutination test of Wright (with 
EDTA) ; RBPT ( Rose Bengal Plate Test), CFT (Complement fixation test) ; iELISA (Indirect Enzyme linked 
immunosorbent assays); 
a 
Detection of IgG1 and/or IgG2 would depend on the conjugate used 
 
1.3.1.2.1.1. Sero-agglutination of Wright (SAW) 
The Sero-agglutination of Wright (SAW) or Slow Agglutination Test (SAT) is the 
oldest diagnostic test of brucellosis. It is an inexpensive and relatively easy to implement 
semi-quantitative test. Different types of SAW exist, from the simple SAW to the SAW-
EDTA where EDTA is added to enhance the specificity of the test by inactivating some non- 
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specific IgM (Alton et al., 1988; Corbel, 2006). It is susceptible to false positive reactions by 
cross-reacting antibodies.  
1.3.1.2.1.2. Rose Bengal Test (RBT)  
The Rose Bengal Test (RBT) is an agglutination test between agglutinating IgM 
immunoglobulins and a colored antigen suspended in an acid buffer (pH 3.65) to prevent 
reaction of non-specific agglutinins. It can be used for diagnosis at the herd level and 
particularly for the sero-surveillance of cattle herds in brucellosis free areas. It is a quite 
sensitive and relatively simple test to apply (OIE, 2009). Although, it is a good screening test 
for brucellosis, it is unable to distinguish vaccinated from infected animals (Corbel, 2006) 
and can produce false positive serological reactions. It is a prescribed test for trade by OIE 
(OIE, 2009). 
1.3.1.2.1.3. Complement Fixation Test (CFT)  
The Complement Fixation Test (CFT) is based on the activation of the complement in 
the presence or not of the antigen-antibody complex. This presence of the complex is 
detected using a hemolytic system. This test is quite specific even if false-positive reactions 
may still occur. Despite its status of prescribed test by the OIE for trade (OIE, 2009), it is a 
difficult and complicated test to implement (Alton et al., 1988). Moreover, it is not well 
standardized and anti-complementary reactions (due to bacterial contamination of the sera, or 
other factors) sometimes make the interpretation of the results difficult (Corbel, 2006).  
1.3.1.2.1.4. Enzyme Linked Immunosorbent Assays  
The indirect Enzyme Linked Immunosorbent Assays (iELISA) use a purified Smooth 
LPS coated on a polystyrene matrix as an antigen (Nielsen, 2002; Saegerman et al., 2004; 
Godfroid et al., 2010). It allows an indirect detection of antibodies against the Brucella 
antigen using various conjugates with enzymes. Indirect ELISA techniques are considered as 
very sensitive tests but do not allow to distinguish between post-vaccination and post-
infective antibodies (OIE 2009). Therefore, competitive ELISAs were developed to improve 
the test specificity (Nielsen et al., 1996a; Portanti et al., 2006) but they are less sensitive 
compared to indirect ELISAs (Nielsen et al., 1995; Samartino et al., 1999a). Competitive 
ELISAs are helpful to eliminate false positives and to discriminate between post-vaccination 
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antibodies due to the vaccine strain S19 and post-infection antibodies (Weynants et al., 
1997). These tests are prescribed for trade by the OIE (OIE, 2009). 
1.3.1.2.1.5. Fluorescence Polarization Assay (FPA)  
The FPA is a highly sensitive, specific, rapid and easy to implement test (Gall and 
Nielsen, 2004). This method consist in the blank reading of the diluted sample in a 
fluorescence polization analyser, addition of an antigen labeled with a fluorochrome and final 
reading after two minutes of incubation (Samartino et al., 1999b). It is based on the rotational 
differences between molecules in solution, the smaller rotating randomly at a rapid rate and 
resulting in a rapid depolarization of light while the larger will rotate slower and depolarize 
light at reduced rate (Nielsen and Gall, 2001). Depending on the presence or absence of an 
antigen-antibody complex, the size of the molecules in the solution will increase (or not) and 
therefore, its rate of rotation will be proportionally reduced (or not). For brucellosis, a small 
subunit of the O Polysaccarhide (OPS) of B. abortus strain 1119-3 smooth 
Lipopolysaccharide (sLPS) conjugated with fluorescein isothiocyanate is added to diluted 
serum, milk or whole blood sample. The test result is obtained by measuring the time of 
rotation in a given angle with a polarized light after incubation (OIE, 2009). The specificity 
of the FPA is quite high even in cattle herds vaccinated with strain 19 (Nielsen et al., 1996b; 
Gall et al., 2000; Gall et al., 2001). It is a prescribed test by OIE for trade (OIE, 2009).  
1.3.1.2.1.6. Brucella Immunochromatographic Lateral Flow 
Assays (LFA)  
The LFA is a rapid test initially developed for the diagnostic of human brucellosis 
(Smits et al., 2003; Irmak et al., 2004, Franco et al., 2007). It was later adapted for the 
serodiagnosis of brucellosis in different livestock species including cattle, sheep, goat and 
pigs (Abdoel et al., 2008). It is a simple test also based on the detection of IgM/IgG against 
Brucella LPS. As in other serological tests, cross-reaction may also occur. LFA does not 
require a specific expertise, expensive equipment, electricity and refrigeration, or a specific 
training. It is also argued to be suitable for remote areas where access to adequate laboratory 
facilities is problematic or when testing animals from nomadic or other migratory livestock 
keepers (Abdoel et al., 2008, Bronsvoort et al., 2009). 
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1.3.1.2.1.7. Milk testing assays  
Serological diagnostic tests applied to milk are good and practical means for screening 
in the dairy sector. They can be easily implemented in milk collection centers. In this case, 
when the test is positive, it implies that all cows which are in production and were milked, be 
tested using other serological tests. The "milk iELISA" is a very sensitive and specific test. 
The Milk Ring Test (MRT), an adaptation of the agglutination test for milk, is also a good 
alternative test in the absence of ELISA because it is very cheap (OIE, 2009). False positive 
reactions are common with MRT especially in brucellosis free areas (Corbel, 2006). 
1.3.1.2.2. Cellular methods 
1.3.1.2.2.1. Skin Delayed-type Hypersensibility Test or Skin Test 
The “Skin Test” or intradermal test with brucellin is based on the hypersensitivity or 
allergic inflammatory reaction of the host after an intradermal injection with a protein extract 
of a rough strain of Brucella (Saegerman et al., 1999; Godfroid et al., 2010). This test is 
based on the specific cell-mediated immunity against Brucella and is able to identify latent 
carriers and to discriminate false positive serological reactions due to Yersinia enterocolitica 
O: 9, when associated with other serological tests (Saegerman et al., 1999; Bercovich, 2000). 
It is highly specific with some disadvantages such as the inability to discriminate between 
infected and vaccinated animals, and the need for at least two visits with an interval of 2 to 3 
days to get the result (Weynants et al., 1995; Cutler et al., 2005). It is prescribed as an 
alternative test by the OIE (OIE, 2009). 
1.3.1.2.2.2. Antigen-Specific Gamma Interferon Production Test  
The antigen-specific Gamma interferon production test is an in vitro test developed in 
order to improve the diagnostic specificity of bovine brucellosis. It is based on the 
quantification of the Gamma interferon (γ-IFN) produced in response to antigenic 
stimulation. It is a delayed-type hypersensitivity test similar to the "skin test" but with a lower 
specificity. It can be used as a complementary test with others serological assays (Weynants 
et al., 1995).  
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1.3.1.3. Identification and typing methods  
Results of identification and typing of Brucella are useful to have a better knowledge of 
the epidemiology of the disease to manage disease outbreaks, to identify appropriate antigens 
and to test and set up efficient preventive and control measures (Crawford et al., 1979; Ica et 
al., 1998; Saegerman et al., 2010; Godfroid et al., 2010). At national and at regional levels, 
identification and typing results from infected animals are helpful to assess potential threats 
for public health since animal hosts are the source of human brucellosis infections. Despite 
their high genetic relation, application of both bacteriological and molecular typing methods 
may be used for identification and typing of Brucella (Scholz and Vergnaud, 2013) as 
discussed above. However, differentiation among species and biovars is sometimes 
complicated because of the existence of strains showing atypical characteristics (Acha and 
Zsyfres, 2003; Scholz and Vergnaud, 2013). Handling and biotyping of Brucella also requires 
facilities, equipment and technical skills that are not always available in diagnostic 
laboratories in Africa, limiting the availability of data on prevailing strains of Brucella 
(Samartino et al., 2005). 
1.3.2. Prevention and control measures  
Given that brucellosis is a zoonotic disease, there is a correlation between human and 
animal brucellosis. Prevention of brucellosis in human mainly depends on the control of the 
disease in the animal hosts (Godfroid et al., 2005; Pappas et al., 2006; Saegerman et al., 
2010). Different strategies for controlling brucellosis exist and have been applied in different 
part of the world (Benkirane, 2001; Godfroid and Kasbohrer, 2002; Ragan, 2002; Samartino, 
2002; Poester et al., 2002; Rivera et al., 2002; McDermott and Arimi, 2002; Saegerman et 
al., 2010, FAO, 2013). The aim of these strategies is to prevent the spread of the infection, to 
reduce the risk of abortion and to increase the herd or population immunity. Strategies for 
controlling brucellosis could include measures as appropriate herd management (Samartino et 
al., 2005), vaccination of the susceptible population, slaughtering of the animals recognized 
positive to testing (Benkirane, 2001), and increase of public awareness and education of 
population at risk (Robinson, 2003). All these measures could be applied separately or in 
combination but need to be backed up by appropriate regulations or legislation. An efficient 
control strategy need to consider some key elements like the true prevalence of the disease 
(Table V), livestock management system, organization of the veterinary services, implication 
of policymakers and communities (stakeholders), availability of resources to sustain control 
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measures, and the intersectoral collaboration between veterinary services and public health 
actors (Benkirane, 2001; Saegerman et al., 2010). In many developed countries, control 
programs including measures such as test-and-slaughter with compensation for farmers, 
accreditation and financial incitation for disease-free herds have been successfully applied to 
control brucellosis (Saegerman et al., 2010). Many countries such as Australia, Belgium, 
Canada, Cyprus, Denmark, Finland, the Netherlands, New Zealand, Norway, Sweden, and 
the United Kingdom have been declared free from bovine brucellosis. In developing 
countries, despite its known endemicity, its socioeconomic impacts and the beneficial effect 
of possible control measures, resources allocated to control of brucellosis are declining or 
absent. Most of the time, vaccination is the only mean applied for the control of animal 
brucellosis in these countries (McDermott and Arimi, 2002). 
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Table V : Control strategies of brucellosis according to the epidemiological status (adapted from Benkirane, 2001; Saegerman et al., 
2010) 
Epidemiological status Control strategy and associated 
measures 
Monitoring method Outcome/ 
next step 
    
A: High prevalence in animals;  
high clinical incidence in humans 
- Mass vaccination 
- Support to veterinary services 
- Rational use of available resources 
- Movement control 
- Serology  
- Bacteriology 
- Monitoring the incidence of human cases 
Go to B 
    
B: Moderate prevalence - Combined prophylaxis  - Counting and identification of animal  
- Serology control 
- Bacteriological monitoring 
- Communication/sensitization/education 
- Intersectoral collaboration with human health 
services 
Go to C 
    
C: Low prevalence (<1%) - Sanitary prophylaxis - Monitoring in farms and slaughter houses 
- Serological monitoring 
- Survey in target groups 
Reach D 
    
D: Absence of the disease - Movement control - Monitoring of risk indicators Preserve this 
status 
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1.3.2.1. Communication and education for prevention 
Communication and education of public at risk are considered as a key component to 
increase the awareness of the disease, to prevent its spread and to reduce occupational and 
food-borne risk linked to zoonotic diseases such as brucellosis (Robinson, 2003). Education 
and sensitizing should be undertaken to prevent the consumption of unpasteurized milk and 
milk derivatives (Samartino et al., 2005). Populations with cultural habits encouraging the 
consumption of milk and the use of its products raw or poorly cooked are highly at risk and 
should be sensitized in priority. Since the disease is likely to be transmitted in a context 
where people have close contact with the animal host, hygienic and biosecurity measures 
during handling and disposal of afterbirths- especially in cases of abortion - should also be 
taught and encouraged, particularly among professionals at higher risk like hunters, farmers, 
butchers, and veterinarians (Corbel, 2006; Saegerman et al., 2012).  
1.3.2.2. Prophylactic measures 
Since Brucellae are facultative intracellular organisms, the effectiveness of 
antibiotherapy is limited. Furthermore, the use of antibiotics for the treatment of brucellosis 
would require the use of massive doses, increasing the risk of antibiotic residues and 
resistance dissemination to humans through the food chain. Implementation of preventive 
medical measures, e.g. vaccination, is therefore a key component for the prevention/control 
of brucellosis. Vaccination is used to increase the resistance of susceptible animals to 
infection, to reduce the expression of clinical signs and to diminish the excretion of Brucella 
by infected animals (Corbel, 2006). In many countries, it was adopted as the most practical 
and economical way for controlling animal brucellosis (McDermott and Arimi, 2002; Aznar 
et al., 2014).  
In Ivory Coast, vaccination was used between 1978 to 1982 during a control program 
conducted by the SODEPRA. Females from 1 to 10 years of age were vaccinated at primo-
vaccination. Then, non-pregnant females of one to two years old were vaccinated every year. 
About 300,000 females have been vaccinated in the north and the centre of the country 
(Angba et al., 1987) using mostly H38, but also B19 vaccine strains. The campaign led to the 
reduction of abortion and mortality rate up to more than 37% (Camus, 1980a; Camus, 1980b; 
Angba et al., 1987). Because of the resurgence of brucellosis, female calves of 4 to 8 months 
of age and non-pregnant cows in dairy farms were vaccinated again in 1992 using a single 
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dose sub-cutaneaous injection as previous years (Camus, 1995). With the privatization of 
SODEPRA in 1993, vaccination activities were transferred to the private sector and were 
progressively abandoned, farmers being henceforth asked to pay for vaccination. Currently, 
there is no official control program or official vaccination against brucellosis in Ivory Coast.  
When vaccination is applied for the control of brucellosis, there might be some 
disadvantages such as its possible interference with most diagnostic tests (serological and 
hypersensitivity). In cattle, the use of S19 vaccine (smooth attenuated strain of B. abortus) is 
recommended but is not effective in protecting animals against infections with B. melitensis 
(Corbel, 1997). The RB51 vaccine (rough attenuated strain of B. abortus) also gives 
satisfaction and seems to interfere very little with serological tests (Schurig et al., 2002). 
Despite a lower efficiency compared to the S19 strain, RB51 vaccine is preferred over the 
S19 in several Latin American countries (Corbel, 2006). 
In addition to medical prophylactic measures, sanitary measures can also be used to 
prevent the introduction and the spread of the disease in a given population. For brucellosis, 
these include hygiene, containment and animal movement control. In addition, the use of 
appropriate and accurate diagnostic tests, allow to identify and eliminate infected or test-
positive individuals. Aiming to prevent the spread of the disease, elimination may imply the 
slaughtering of positive tested animals (test-and-slaughter). The efficiency of these methods 
depends on the epidemiological context, the availability of sustainable resources and 
appropriate regulation. In many developed countries, test-and-slaughter was applied in a 
control strategy for brucellosis, in combination with compensation of farmers, accreditation 
and financial incentives for disease-free herds (Saegerman et al., 2010, Godfroid et al., 
2013). Also known as stamping out method, test-and-slaughter is generally implemented in 
association with vaccination (Corbel, 1997). In effect, vaccination is first used to prevent or 
control the infection among infected host, and then it is gradually restricted while test-and-
slaughter is implemented to eliminate the infection. Availability of an appropriate financial 
compensation scheme is the main limiting factor of the implementation and the success of 
any control program including test-and-slaughter policy (Seleem et al., 2010; Godfroid et al., 
2013), particularly in low resource countries. The success of the application of this measure is 
unlikely if the herd level prevalence is more than 2% (Corbel et al., 2006).  
1.3.2.3. Intersectoral collaboration for control 
The efficiency of prevention and control measures of zoonotic diseases like brucellosis 
requires the implication and the collaboration of both animal and human health sector. It is 
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expected to ensure joint administrative arrangements, facilitate cross-notification of cases, as 
well as coordinated investigations, surveillance and prevention/control activities, and public 
health education programs (Corbel, 2006). Such collaboration should be encouraged at both 
national and regional level, in order to put together limited resources and capabilities for an 
efficient control. Thus, emerging concepts such as the “One health approach” can be 
considered as an opportunity to improve human health and well-being through an integrated 
management of pathogens as Brucella spp in both humans and domestic animals (Saegerman 
et al., 2010; Saegerman et al., 2012; Marcotty et al., 2013). This approach is expected to be 
particularly beneficial in low resource societies where different disciplines could be 
combined to improve the strength of the surveillance and the control of infectious diseases 
like brucellosis. 
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CHAPTER 2: EPIDEMIOLOGICAL CONCEPTS AND METHODOLOGIES 
This chapter describes the epidemiological tools used in the thesis.  
2.1. Systematic review and meta-analysis  
Reliable and good quality data or information are essential to support decision-making 
and for answering urgent questions. Most of the time, such data or information are provided 
by systematic review or meta-analysis. They gather data or results from several studies into a 
single synthesis (Montori and Guyatt, 2003, Leeflang et al., 2008). Synthesizing results from 
several studies can be done in many ways but not all of these are scientifically robust (Honest 
and Khan, 2002).  
Systematic reviews allow a synthesis of relevant studies by applying scientific strategies that 
limit biases (Wright et al., 2007). A systematic review is a review of a clearly formulated 
question that uses systematic and explicit methods to identify, select, and critically appraise 
relevant research, and to collect and analyze data from the studies that are included in the 
review (Moher et al., 2009). Thus, when doing a systematic review, the author(s) should i) 
address a defined question; ii) conduct a detailed and exhaustive search for relevant studies; 
iii) include studies of high methodological quality; and iv) use reproducible approaches to 
assess the limitations in the methodological quality of the studies on which they focus 
(Montori and Guyatt, 2003). When similar individual studies are summarized, they can be 
pooled together and analysed statistically using a meta-analysis (Deeks, 2001; Gatsonis and 
Paliwal, 2006; Wright et al., 2007). Applications of recommended guidelines are useful to 
ensure good quality of both systematic reviews and meta-analysis (Moher et al., 2009).  
2.2. Logistic regression analysis 
A range of statistical methods is available to analyze data from epidemiological studies 
according to the objectives. When epidemiological studies are aiming to demonstrate or 
identify relationships between different factors or variables of interest, regression methods 
are mostly used (Lewis and Michael, 2013). These methods are helpful to identify and 
describe potential associations that might exist between variables of interest such as the 
serological status of an animal (known as dependent response or outcome variable) and the 
sex and the age of this animal (independent predictive variables or explicative variables). 
When the outcome or the response variable is dichotomous such as disease status 
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(seropositive or seronegative), the logistic regression modeling was applied. It is therefore 
used to identify statistical associations among variables of interest and to identify variables 
that might be relevant for disease control (Lewis and Michael, 2013).  
Logistic regression is among the most important regression techniques in epidemiology 
(Stephen, 2001). It is the most appropriate modeling approach to describe and to test 
hypotheses about relationships between a categorical outcome and one or more categorical or 
continuous predictor variables. Dohoo et al. (2003) provided more discussions on logistic 
regression modeling. Briefly, estimations in logistic regression modeling are obtained 
through a Maximum Likelihood Estimation process. In this later approach, the coefficients in 
the model represent the amount of the logit of the probability of the outcome changes with a 
unit increase in the predictor variable. Since these coefficients are hard to interpret, they are 
commonly expressed as odds ratios (OR). When, the predictor variable is continuous, the OR 
represents the factor by which the odds of outcome variable are increased (or decreased) for 
each one-unit change in the predictive variable. When, the predictor is a categorical variable, 
the coefficient for each level of the variable represents the effect of that level compared to the 
category (i.e. the 'baseline') not included in the model (Dohoo et al., 2003). 
2.3. Determination of disease status 
Determining the status of a given individual regarding a given condition could be helpful 
for many purposes. Knowledge of a disease status can be used to support decision for 
diagnosis or for treatment. Identification of the status of an individual in a given population 
could also be required to assess a new diagnostic test. Determining a disease status implies 
the use of appropriate diagnostic tools or tests. When the diagnostic test is able to determine 
the disease status of an individual with 100% accuracy, it is considered as the gold standard 
test. In practice, gold standard tests are seldom available due to many factors including the 
biological variability of each individual. Therefore, disease status has to rely on so-called 
“bronze” test or another test closest to the standard test. As an alternative to the absence of a 
gold standard test, a combination of tests could also be used to improve the diagnostic 
performance or obtain a gold standard effect (Black and Craig, 2002). This is often the case 
with brucellosis for which an unequivocal diagnosis can be made only with the isolation and 
identification of Brucella (OIE, 2009). However, isolation and identification methods as 
Brucella culture are not always available or feasible in common diagnostic conditions 
contrary to serological tests (Nielsen, 2002; Godfroid et al., 2010). In addition, the 
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probability of finding  Brucella spp. can decrease one month after the parturition as 
previously assessed (Saegerman et al., 2004).  
When a combination of tests is used, results can be interpreted in series or in parallel 
according to the objectives of testing. With serial interpretation, only animals that give 
positive results to both tests are considered positive. Consequently, this increase the 
diagnostic specificity (Sp) and decrease the diagnostic sensitivity (Se). With parallel 
interpretation, animals that give a positive result to one of the tests or to both tests are 
considered positive. Conversely to serial interpretation, parallel testing increases Se and 
decreases Sp. Depending on the fact that diagnostic tests target the similar biological 
phenomenon or not, combined tests could be considered as either dependent or independent. 
The combined tests may be correlated if they measure or target a similar biological 
phenomenon such as immunoglobulins (Gardner et al., 2000; Dendukuri and Joseph, 2001). 
When two tests are combined, the presence of a positive dependence would respectively 
reduce the test sensitivity value in a parallel interpretation scheme and the test specificity 
value in a serial interpretation scheme compared with values expected if tests were 
conditionally independent (Gardner et al., 2000). More discussions on test dependence issues 
are provided in further sections. 
2.4. Estimation of disease true prevalence and performance of diagnostic tests 
2.4.1. Estimation of disease true prevalence  
Disease prevalence is a key parameter to assess the impact of a disease in the 
population of interest and for estimating the disease burden (Speybroeck et al., 2012a). To 
determine the actual level of a disease in a population of interest, the true prevalence needs to 
be estimated (Dohoo et al., 2003). Accuracy of true prevalence is related to performance 
parameters of tests to be applied (Ihorst et al., 2007). Assuming that the sensitivity (Se) and 
the specificity (Sp) of a given diagnostic test are known, and AP being the apparent 
prevalence resulting from the application of the test in the population of interest, the true 
prevalence (P) can be determined using the following formula (Rogan and Gladen, 1978): 
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The estimation of the disease true prevalence is then straightforward with this formula 
when a gold standard test is available or fixed and known values are assumed for test 
characteristics (Dohoo et al., 2003; Berkvens et al., 2006). In practice, fixed and known 
values assumption may be unrealistic. Moreover, a straightforward application of this 
formula may result into estimates exceeding 1 (one) or may yield negative values (Spybroeck 
et al., 2012a; Lewis and Torgerson, 2012). In addition, perfect reference tests are hardly ever 
available since diagnostic performance of any test is known to be influenced by several 
endogenous and exogenous factors and should be considered as context-specific parameters 
(Saegerman et al., 2004; Berkvens et al., 2006; Rutjes et al., 2007). All these elements imply 
that imperfect tests should be used for disease prevalence estimation. Additionally, the use of 
multiple imperfect tests for estimation is suggested to reduce misclassification errors. So, 
appropriate methods and assumptions should be used to get unbiased estimates (EnØe et al., 
2000; Berkvens et al., 2006). 
2.4.2. Assessment of performance of diagnostic tests  
The performance and the accuracy of all diagnostic assays need to be determined under 
routine conditions. This includes the estimation of parameters measuring the accuracy and the 
diagnostic performance of assays. While the reproducibility of a test measures the degree of 
agreement between test results when the conditions for testing or measurement change (e.g., 
two operators or laboratory technicians or two laboratories), the repeatability expresses the 
similarity of the test results in the same conditions (OIE, 2013). The robustness of an assay is 
another parameter  referring to the assay’s capacity to remain unaffected by minor variations 
(e.g., pH, temperature of reagents, brand of microtiter plates) while using an assay in the 
single laboratory conditions.  
During this thesis work, agreement between test results was assessed using indexes of 
agreement as indicator and sensitivity and specifity as diagnostic test performance 
parameters. 
2.4.2.1. Indicators of agreement between tests  
In order to increase the diagnostic performance, to assess a new diagnostic test or to 
evaluate test characteristics, two diagnostic tests can be used in combination. Different 
indicators can be used to assess the agreement between the results of the different tests. The 
most commonly applied is the kappa coefficient of agreement (K). It is the corrected index of 
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the agreement between the results of two diagnostic tests. It is calculated as the ratio of the 
observed excess over chance agreement to the maximum possible excess over chance. The 
kappa coefficient is equal to 1 (100%) when there is perfect agreement and it takes the value 
of zero when the observed agreement is equal to the chance agreement (Dohoo et al., 2003). 
However, the kappa coefficient is under the influence of the prevalence. Moreover, it was 
noticed that despite a high concordance between two tests, the kappa coefficient may 
paradoxally be low (Feinstein and Cicchetti, 1990; Cicchetti and Feinstein, 1990). To solve 
paradoxes with kappa coefficient, two indexes, e.g., the positive and negative index of 
agreement were proposed to measure the level of agreement between two tests (Cicchetti and 
Feinstein, 1990; Graham and Bull, 1998). These indexes represent respectively the observed 
agreement proportion for positive and negative results. Using the contingency table (Table 
VI), the two indexes of positive agreement (Ppos) and negative agreement (Pneg) are 
respectively: 
ppos 
2a
2ab c
   and   pneg 
2d
2d b c
 
Where Ppos and Pneg are respectively the indexes of positive agreement and negative 
agreement; a, b, c and d are given in the contingency table.  
Table VI : Contingency table showing results for two diagnostic tests (Test 1 and Test 2) 
  Test 1  
  pos neg Total 
Test 2 
pos a b a+b 
neg c d c+d 
 Total a+c b+d N 
pos: positive result; neg: negative result 
2.4.2.2. Performance parameters of diagnostic tests  
In both human and animal health, diagnostic tests are useful tools to determine the true 
disease status of an individual or a group of individuals in a population of interest. For a 
given disease, the accuracy of information on individual’s status depends on the performance 
of the applied diagnostic tests. In fact, the performance of a diagnostic test indicates its ability 
to correctly identify truly diseased from non-diseased individuals when applied in a randomly 
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chosen sample from a population of interest (Lewis and Torgerson, 2012). This ability is also 
an important point when evaluating a new diagnostic test and for implementing disease 
control programs since a correct classification of herds and individual animals regarding their 
status is looked-for (Greiner and Gardner, 2000). The actual level of a disease in a population 
of interest, i.e. the true prevalence, is also an essential parameter (Dohoo et al., 2003). Its 
estimate is helpful to assess the impact of a disease in the population of interest and to avoid 
biased estimation of disease burden (Speybroeck et al., 2012a). Accuracy of true prevalence 
depends on the performance parameters of the tests to be applied (Ihorst et al., 2007). The 
performance of a diagnostic test may be evaluated through several quantitative parameters 
including predictive values, likelihood ratios (LR), the area under the Receiver-Operating-
Characteristic (ROC) curve (AUC), the diagnostic odds ratio (DOR), Youden's index (J), and 
Se and Sp (Greiner and Gardner, 2000; Glas et al., 2003). These parameters are helpful to 
support decision-making while selecting a diagnostic test for a given context or purpose. 
Based on the contingency table below (Table VII), a summary of these different parameters 
of performance and their definitions are given in Table VIII (Glas et al., 2003). 
The predictive values express the probability of diseased animals (PPV) or non-
diseased animals (NPV) among positive and negative results respectively. The likelihood 
ratios indicate the ratio of the expected result between animals with a disease and animals 
without that disease. The area under the ROC curve (AUC) is a plot of sensitivity against one 
minus the used specificity and is applied to measure the discriminative power of a diagnostic 
test. The Diagnostic Odds Ratio (DOR) is referred as the ratio of the odds of positivity in 
diseased animals compared to the odds of the same test result in non-diseased animals. Both 
DOR and the Youden’s index, which is a combination of sensitivity and specificity minus 
one, are significantly influenced by these two parameters. Among the indicators of 
performance, sensitivity and specificity are the most employed. Test Se (or Sp) indicates the 
probability that a truly infected (or non-infected) individual yields a positive (or a negative) 
test result. Similarly, when the epidemiological unit of concern is the herd, Se corresponds to 
the probability that an infected herd yields a positive herd-test result, and herd-level Sp (HSp) 
is the probability that a non-infected herd yields a negative herd-test result (Martin et al., 
1992). Positive herd result might refer to the presence of at least one animal testing positive 
within this herd while negative herd result corresponds to absence of positive animals. 
However, the threshold number of positive animals that denotes the herd as positive needs to 
be determined.  
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Table VII: Contingency table showing results between a reference test and a given 
imperfect test (Test) 
  Reference test 
  Diseased Not diseased 
Test Positive TP FP 
Negative FN TN 
Where TP, FP, FN, TN are respectively the True positive, the False positive, the False 
negative and the True negative. 
 
Table VIII: Definitions of commonly used performance indicators of diagnostic test 
(Glas et al., 2003) 
 
Test performance 
Parameters 
Formula Definition 
   
Accuracy (TP+TN)/(TP+TN+FP+FN)  Proportion of correctly identified subjects 
   
Sensitivity (Se) TP/(TP+FN)  Proportion of positive test results among 
diseased (true positive rate) 
   
Specificity (Sp) TN/(TN+FP)  Proportion of negative test results among 
the “healthy” (true negative rate) 
   
Positive predictive value 
(PPV)  
TP/(TP+FP) Proportion of diseased among subjects 
with a positive test result 
   
Negative predictive value 
(NPV)  
TN/(TN+FN) Proportion of non-diseased among 
subjects with a negative test result 
   
Likelihood ratio of a positive 
test result (LR+) 
Se/(1-Sp)  Ratio of a positive test result among 
diseased to the same result in the 
“healthy” 
   
Likelihood ratio of a negative 
test result (LR-)  
(1-Se)/Sp  Ratio of a negative test result among 
diseased to the same result in the 
“healthy” 
   
Youden’s index (J) Se +Sp-1 Difference between the true positive rate 
and the false positive rate 
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2.4.3. Methods for estimating disease true prevalence and test sensitivity and 
specificity  
2.4.3.1. Estimation at individual-level  
As mentioned above, diagnostic tests are useful to detect the presence or evidence of 
the presence of an infection or a disease. This ability of a diagnostic test to detect a condition 
of interest is crucial for selecting appropriate control strategies. So, the performance of a 
diagnostic test is of key importance. However, since this performance might be influenced by 
several variables, appropriate methodologies are needed to get better estimates of 
performance parameters. Estimation of test performance parameters and the true prevalence 
are two mathematically identical situations, even if the parameter of interest might change 
according to study objectives (Lewis and Torgerson, 2012).  
When a gold standard test is available, the true status of an epidemiological unit of 
interest regarding a disease can be determined. As a result, performance parameters and true 
prevalence can be easily deduced from the Rogan-Gladen equation, putting into relation 
apparent prevalence (AP) and true prevalence ( ) with test sensitivity (Se) and specificity 
(Sp), as described previously (Rogan and Gladen, 1978). 
However, assuming a test is a “gold standard” test would mean that no classification errors 
exist and no false positive or negative result is possible. In practice, such a perfect reference 
test is hardly ever available since diagnostic performance of any test is known to be under the 
influence of several endogenous and exogenous factors (Rutjes et al., 2007). As an alternative 
to the absence or the unavailability of a gold standard test (Black and Craig, 2002), the use of 
multiple imperfect tests was suggested to facilitate estimation. With multiple tests, 
misclassification errors are reduced and expected to be lower compared to the application of a 
single imperfect test. Over the years, several authors have attempted to provide options or 
solutions to get better and unbiased estimates of the disease prevalence and test Se and Sp in 
different settings and particularly in absence of a gold standard reference test. These solutions 
were inspired by frequentist and Bayesian concepts, the two statistical approaches through 
which inference to the population is made (see section 2.4.3.3.).  
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2.4.3.2. Estimation at herd-level  
Test properties and prevalence estimation could also be considered at group or herd 
level. Indeed, for many diseases, control programs include groups of individuals or herd 
testing. Like for individual testing, herd level test performance parameters are crucial. 
Christensen and Gardner (2000) and Martin et al. (1992) discussed the evaluation of 
diagnostic tests at herd level. Assuming known individual test characteristics and a cut-off of 
at least one animal testing positive for a herd to be considered positive, herd Se (HSe) and Sp 
(HSp) are computed as in Thrusfield et al. (2005). Dohoo et al. (2003) provided a general 
formula covering the cases with more than one positive animal to consider the herd as 
positive. Group or herd level test characteristics were shown to be under the influence of 
different factors. These factors include individual level test Se and Sp, sample size, threshold 
number (or the percentage of positive tests that denote the herd, or group as test positive) and 
the within-herd prevalence (Martin et al., 1992). The threshold number of positivity or 
minimum within-herd prevalence is usually determined according to the epidemiology of the 
disease or specific national or international rules (Wagner and Salman, 2004). Usually, the 
presence of one animal testing positive within a herd would be sufficient to classify it as 
positive but more than one positive result could be necessary for some diseases (Pfeiffer, 
2002). Herd size is also known to have a significant influence on herd test performance 
(Pfeiffer, 2002). Herd-level test performance estimation is comparatively less complicated 
when herd size in the population of interest is constant. Estimation becomes more challenging 
when the herd size varies. Then, the procedure for estimating the herd-level test performance 
needs to account for this variability by weighting estimated values using herd size. As for 
individual testing, a single test or a combination of test could be used for herd level testing to 
improve testing performance. Similar requirements as for individual Bayesian modeling also 
applies when herd is considered, with also the need of good quality prior information
7
.  
                                                 
 
7 When prior knowlegde provides information on the uncertainty of a parameter to be estimated, it is 
considered as an“informative prior”. Conversely, prior knowledge might be unavailable implying an 
absence of information on the uncertainty of a parameter to be estimated. This lack of knowledge can 
be included in the modelling process as a“non-informative prior”. 
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2.4.3.3. Bayesian versus frequentist methods for estimating the disease 
true prevalence and diagnostic test performance 
 
This section constitutes a personal view published in The Veterinay Journal. 
ARTICLE 1:  
SANOGO M., ABATIH E., SAEGERMAN C. Bayesian versus frequentist methods for 
estimating disease true prevalence and diagnostic test performance. Vet. J., 2014, 202, 204 -
207.  
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CHAPTER 3: OBJECTIVES OF THE THESIS 
In many developing countries such as Ivory Coast, the development of livestock and 
the improvement of their health environment is part of the fight against poverty and for food 
security of populations. Developing livestock production and productivity imposes dealing 
with many constraints including pathological ones such as brucellosis. In addition to its 
impact on animal’s health, brucellosis is also one of the widespread zoonotic diseases. In 
developing countries and more precisely in Africa, this disease is endemic and known to be 
among the pathologic constrains to the development of livestock. Despite its known negative 
socio-economic impact and zoonotic potential, the disease is not considered yet as a priority 
disease and therefore remains neglected, underreported and uncontrolled in many countries 
(Mableson et al., 2014). 
In Africa, bovine brucellosis is the most widespread form among animals. In Ivory 
Coast, this form was recognized as one of the dominant pathologies and is argued to be 
responsible for the loss of about 10% of the annual income of the livestock breeders (Angba 
et al., 1987). In this country, investigations were conducted on bovine brucellosis throughout 
the years to determine its incidence and for a better knowledge of its epidemiology (Gidel et 
al., 1974; Pilo-Moron et al., 1979; Camus, 1980a; Thys et al., 2005). But similarly to many 
low-resource countries, these investigations are still few and their results are outdated 
particularly on the actual distribution of the disease, on the transmission within and across 
species and the impact on human and animal health, precluding the development of 
prevention and control strategies (Marcotty et al., 2013).  
The general objective of the research presented in this thesis is to improve the knowledge on 
the epidemiology of bovine brucellosis in Ivory Coast permitting future strategic actions. In 
this respect, different aspects of the disease were studied including prevailing strains causing 
brucellosis in cattle, performance of diagnostic test for brucellosis, estimation of true disease 
prevalence and identification of risk factors associated with brucellosis seropositivity in cattle 
from Ivory Coast (Figure 9).  
The specific objectives of the research are as follows: 
1) Identification and isolation of the causal agent remains the ultimate evidence of the 
presence of the disease. The demonstration of Brucella as causal agent of brucellosis may 
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be done through various methods including bacteriological and molecular methods. 
Knowledge on prevailing field strains of Brucella in the particular context of Ivory Coast 
is useful to elaborate and set up appropriate preventive and control measures against 
brucellosis. In effect, data on prevailing field strain would be useful and critical to select 
the appropriate antigen for serological assay, to determine intra-species and interspecies 
transmission and to assess the potential risk of human infection. Consequently, one of the 
specific objective of this research was to investigate circulating species and biovars of 
Brucella associated with cattle in Ivory Coast (Chapter 4 and 5) aiming to provide an 
overview, to determine their geographical distribution and discuss public health 
implications (Chapter 4). 
2) Diagnostic test are key components for disease-control programs since they are useful for 
classifying individuals according their serological status. Estimates of performance 
parameters are also useful to assess the impact of a disease in a given population, through 
accurate estimates of true prevalence. Thus, since the performance of diagnostic tests are 
under the influence of the population in which they are applied (including prevailing 
disease-causing agent), the diagnostic sensitivity, specificity and the true prevalence were 
estimated for bovine brucellosis in the Ivorian context (Chapter 5 and 6). The 
performance of the diagnostic tests was also discussed in light of circulating field species 
and biovars of Brucella, regarding particularly the appropriateness of the antigen used in 
serological assays. The true prevalence of brucellosis was estimated in Ivory Coast using 
a Bayesian approach, a statistical methodology allowing the combination of many testing 
results for accurate estimates. 
3) Identification of risk factors related to the presence or the spread of the disease are useful 
to adjust preventive and control measures. So, another specific objective of this research 
was to investigate the potential risk factors associated with bovine brucellosis in Ivory 
Coast (Chapter 7).  
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Figure 9: Schematic summary of the main objectives of the thesis 
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4.1. Introduction  
Identification and characterization of the causative agent of an infectious disease is 
important to consider for epidemiological studies, management of outbreaks and to identify 
potential source of human infection (Saegerman et al., 2010; Godfroid et al., 2010). 
Additionnaly, it allows to obtain data on possible interspecies and intra-species transmission 
of Brucella. Knowledge of prevailing species and biovars of Brucella infecting the livestock 
is a crucial prerequisite to the formulation of strategies for the prevention and the control of 
brucellosis in animal populations (Ocholi et al., 2004). Aiming to contribute to the knowledge 
on prevailing strains of Brucella in Ivory Coast and in West Africa, a summary and some 
updates were provided in this thesis. 
4.2. Prevailing species and biovars of Brucella in cattle and their implications 
This section constitutes the following original paper published in Veterinary Microbiology. 
 
 
 
 
ARTICLE 2:  
SANOGO M., ABATIH E., THYS E., FRETIN D., BERKVENS D., SAEGERMAN C. 
Importance of identification and typing of Brucellae from West African cattle: a review. Vet. 
Microbiol., 2013b, 164, 202–211. 
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5.1. Introduction 
Sufficient knowledge on species and biovars of Brucella at national and regional scales 
are important to set up and implement efficient control measures against brucellosis. From 
data on circulating field strains, the appropriateness of the antigen used in serological tests 
can be verified. This appropriateness is of key importance since the detection of the presence 
or evidence of the presence of an infection or a disease such as brucellosis is dependent on 
diagnostic tests. The ability of a diagnostic test to detect a condition of interest can be 
measured through performance indicators such as sensitivity and specificity. Since test 
sensitivity and specificity are known to be under the influence of several variables, an 
appropriate methodology is needed to get accurate and unbiased estimates and to get 
knowledge on the actual impact of the disease among a population of interest. In this chapter, 
typing results were put in relation with the epitope used in the serological tests applied to 
assess their appropriateness. Then, a Bayesian approach was implemented to determine the 
performance of two commonly used diagnostic tests for the diagnostic of bovine brucellosis 
in Africa, the Rose Bengal Test and the indirect enzyme linked immunosorbent assay. For 
representativeness, data from two surveys were combined for the analysis as a single 
population. Indigenous cattle of Bos indicus type, Bos taurus type and their crossbred, more 
than one year old were included in this study. Hygroma fluid collected from a carpal hygroma 
was used as sample for biotyping. 
 
5.2. Bayesian estimation of true prevalence, sensitivity and specificity of Rose Bengal 
Test and indirect ELISA for the diagnosis of bovine brucellosis in Ivory Coast  
This section constitutes the following original paper published in The Veterinary Journal. 
 
ARTICLE 3:  
SANOGO M., THYS E., ACHI Y.L., FRETIN D., MICHEL P., ABATIH E., BERKVENS 
D., SAEGERMAN C. Bayesian estimation of true prevalence, sensitivity and specificity of 
Rose Bengal test and indirect ELISA for the diagnosis of bovine brucellosis. Vet. J., 2013a, 
195, 114-120. 
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6.1. Introduction 
The actual level of a disease in a population of interest, i.e. the true prevalence, is an 
essential parameter to assess the impact and importance of a disease in the population of 
interest and to avoid biased estimation of disease burden. Accuracy of true prevalence is 
related to performance parameters of tests to be applied. Estimation of test performance 
parameters and the true prevalence are two mathematically identical situations, even if the 
parameter of interest might change according to study objectives. By definition, estimation of 
sensitivity and specificity of a diagnostic test requires knowledge of the true disease status of 
animals on which this test is applied. This status is given by a reference test, which might be 
a “gold standard” test. In the absence of a “gold standard” test, a combination of available 
imperfect tests may be used for estimation. An appropriate methodology being needed for 
accurate estimation, a Bayesian approach was used to estimate the true prevalence of bovine 
brucellosis in the centre of Ivory Coast.  
 
6.2. Prevalence of bovine brucellosis in Ivory Coast  
This section constitutes the following original paper published in La Revue d'élevage et de 
médecine vétérinaire des pays tropicaux. 
 
ARTICLE 4:  
SANOGO M., CISSE B., OUATTARA M., WALRAVENS K., PRAET N., BERKVENS D., 
THYS E. Etude la prévalence de la brucellose bovine dans le centre de la Côte d'Ivoire. Rev. 
Elev. Med. vet. Pays trop., 2008, 61 (3-4), 147-151.  
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7.1. Introduction 
In addition to knowledge on circulating field strains of Brucella and availability of 
adequate diagnostic tests, identification of potential risk factors associated with the disease 
is also useful for developing and implementing preventive and control measures. Such 
knowledge might be useful to increase the awareness of farmers, and regulating herd 
management practices with the ultimate aim of to decrease the prevalence of brucellosis 
among livestock in Ivory Coast.  
 
7.2. Risk factors associated with brucellosis seropositivity among cattle in the 
central savannah-forest area of Ivory Coast  
 
This section constitutes the following original paper published in Preventive Veterinary 
Medicine. 
 
 
 
ARTICLE 5:  
SANOGO M., ABATIH E., THYS E., FRETIN D., BERKVENS D., SAEGERMAN 
C. Risk factors associated with brucellosis seropositivity among cattle in the central 
savannah-forest area of Ivory Coast. Prev. Vet. Med., 2012, 107(1-2), 51-56.  
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CHAPTER 8: GENERAL DISCUSSION, CONCLUSIONS AND PERSPECTIVES 
8.1. General discussion 
The need to ensure a sustainable development of livestock, to fight poverty and to limit 
the public health impact of neglected zoonotic diseases as brucellosis, imposes to give 
consideration to these diseases in low income countries. In West African countries including 
Ivory Coast, bovine brucellosis is known for many years and evidence was already provided 
on the benefit to implement control measures against this disease (Camus, 1995; Roth et al., 
2003). However, there is still a lack of attention for brucellosis, hindering any evidence-based 
control measures in most countries. In addition to the need for sufficient and reliable data for 
a better understanding of its epidemiology, updated knowledge on the disease appeared to be 
essential in Ivory Coast. Indeed, the country has recently suffered from political instability 
causing the disorganization and inadequate coverage of veterinary services that are in charge 
of the animal disease control activities. This situation could have favored the emergence of 
animal diseases, especially zoonotic ones like brucellosis (Roth et al., 2003). 
Our research aimed to improve the knowledge on the epidemiology of bovine 
brucellosis in Ivory Coast. Through this general objective, the research intended to generate 
useful information, which could be used to prevent the spread of the disease and to document 
national or regional (future) preventive and control plans and strategies against brucellosis, 
especially in cattle. Therefore, this research includes different contributions intending to 
cover the main aspects of epidemiology of the disease as defined by Carr et al. (2007):  
- The distribution and frequency of bovine brucellosis and evidence of its presence in 
Ivorian cattle; involving specifically: 
o The identification and typing of prevailing field strains of Brucella in cattle;  
o The assessment of field serological diagnosis test for the diagnostic of bovine 
brucellosis; 
o The estimation of the true prevalence of the disease in cattle; 
- The determination of association of brucellosis with other factors, including the 
identification of potential risk factors associated with brucellosis seropositivity in 
cattle. 
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The following sections of the thesis present a general discussion of the research with 
emphasis on the limitations. More details discussions are included within the different articles 
composing the second part of the thesis.  
8.1.1. Importance of identification and typing of prevailing strains of 
Brucella in cattle  
As recentlty expressed by Godfroid et al. (2013), accurate knowledge on Brucella spp in 
both human and the different animal species is needed to identify the source of infection and 
plan appropriate control measures. In this research, a comprehensive summary of species and 
biovars of Brucella reported in West African countries with their proportion per origin and 
their geographical distribution was obtained by applying a systematic review approach (See 
Chapter 4). So far, B. abortus biovar 3 was found to be the most commonly isolated in cattle 
in the sub-region while the biovar 1 is considered as the most encountered worldwide 
(Corbel, 1997), and also in the USA (Bricker et al., 2003) or in Latin America (Acha and 
Szyfres, 2003). B. abortus biovar 3 was also predominantly isolated in both native cattle and 
buffalo in eastern Africa and China (Timm, 1982, Domenech et al., 1983). Despite the 
usefulness of the global map provided on what is known so far about the prevailing field 
strains of Brucella in cattle in West Africa, this review cannot be assumed as exhaustive and 
representative of the actual situation. However, it provides an insight on the status of field 
strains at both national and regional level what is useful considering the frequent and 
uncontrolled cattle movement (transhumance) between countries. On West African scale, 
data on prevailing Brucella in cattle have been lately gathered in The Gambia (Bankole et al., 
2010), in Niger (Boukary, 2013), in Ivory Coast (Sanogo et al., 2013a) and in Togo (Dean et 
al., 2014). Similar research initiatives need to be encouraged for more updated and extended 
data on prevailing field strains of Brucella in West Africa. Except for the Ivorian isolate, 
which appeared to be negative at oxidase test, the five late B. abortus biovar 3 from West 
Africa showed identical growth characteristics. Using enhanced molecular typing methods, 
they showed some dissimilarities despites their classification in the same biovar. The isolates 
from the Gambia and Niger apparently closer genetically, seem to be more distinct from 
those of Ivory Coast and Togo (Table IX and Figure 10). This provides some indications on 
the genetic diversity of circulating strains of Brucella in this sub-region (Dean et al., 2014) 
and the need for further typing results. 
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Table IX: The Multiple Loci Variable Number Tandem Repeats analysis (MLVA) 
profiles showing number of variable tandem repeats (VTR) for latest west African 
isolates of B. abortus biovar 3 and their closest MLVA neighbour profile (B. abortus 
biovar 3 strain BCCN 93_26 from in Sudan, B abortus biovar 3 reference strain Tulya 
from Uganda and B. abortus biovar 6 strain BfR7 from Chad) in the Brucella 
MLVAbank (from Bankole et al., 2010, Sanogo et al., 2013a and Boukary et al., 2013, 
Dean et al., 2014) 
 
 Variable 
tandem 
repeats 
Reference 
Strain 
Tulya 
Strain 
BCCN
a
 
93_26 
Strain 
BfR7
b
 
IVC_isolate Niger_isolate 
The 
gambia_isolate 
Togo_isolate 
1 
Togo_isolate 
2 
Togo_isolate 
3 
P
an
el
 1
 
bruce06 3 3 3 3 3 3 3 3 3 
bruce08 5 5 5 5 5 5 5 5 5 
bruce11 5 5 5 4 3 4 3 3 3 
bruce12 11 11 11 11 11 11 11 11 11 
bruce42 2 2 2 2 2 2 2 2 2 
bruce43 2 2 2 2 2 2 2 2 2 
bruce45 3 3 3 3 3 3 3 3 3 
bruce55 3 3 3 3 3 3 3 3 3 
P
an
el
 2
 
bruce18 8 6 6 7 8 7 10 8 8 
bruce19
c
 - - - 21 21 - 41 41 41 
bruce21 8 8 8 8 8 8 8 8 8 
bruce04 6 6 6 4 6 5 4 4 4 
bruce07 5 8 4 5 2 5 2 2 2 
bruce09 3 3 3 3 3 3 3 3 3 
bruce16 11 7 8 7 12 3 8 5 6 
bruce30 5 7 4 3 7 5 4 4 4 
a
Brucella Culture Collection; 
b
Federal Institute for Risk Assessment; 
c
 additional locus comprised in 
the MLVA-16 and absent in MLVA-15, Isolates from Ivory Coast (IVC_isolate), Niger 
(Niger_isolate) , The Gambia (The Gambia_isolate) and Togo (Togo_isolate 1 , 2 and 3). 
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Figure 10: Dendrgram showing the relation between the latest isolates of B. abortus 
biovar 3 in West Africa and also with neighbour reference strains in the Brucella 
MLVAbank (B. abortus biovar 3 strain BCCN 93_26 from in Sudan, B abortus biovar 3 
reference strain Tulya from Uganda and B. abortus biovar 6 strain BfR7 from Chad) 
(Bankole et al., 2010; Sanogo et al., 2013a; Boukary et al., 2013, Dean et al., 2014). It is 
built from results of a simple linkage cluster analysis of the number of variable tandem 
repeats (VNTR) and the dissimilarities between strains is measured through the 
eucludian distance between VNTRs (L2 dissimilarity measure).  
Regarding Ivory Coast, our study is significant as it was the first report on biovar 3 of 
B. abortus in the country since the first evidence of brucellosis was made (Figure 11). In this 
country, only B. abortus biovar 1 and 6 had been isolated from cattle so far. The new biovar 
was identified from hygroma fluid samples collected from a cow with a carpal hygroma in 
the central part of the country (Chapter 5). This result stresses the importance and the need 
to continue the efforts to identify circulating field strains in Ivory Coast and at a broader 
extent, in other West African countries. Until now, only 18 isolates were reported in Ivory 
Coast since the first report in the early 1970s (Figure 11). This is far less compared to the 
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number of isolates in Senegal (n=232), in Nigeria (n=46), and in Togo (n=30) (Chapter 4). 
All biovars of Brucella reported so far in Ivory Coast (B. abortus biovar 1, 3 and 6) are 
characterized by the same “A” epitope” used in the applied serological tests (i.e., RBT and 
iELISA). This provides an indication on the appropriateness and the adequacy of the 
serological tests used so far. However, there is a need for more investigations and more data 
on prevailing strains of Brucella to support this assumption. 
 
 
Figure 11: Mapping of field strains of Brucella in cattle in Ivory Coast, 2013 (from Pilo-
Moron et al., 1979; Sanogo et al., 2013a; Sanogo et al., 2013b). Each bubble contains 
information on the name of the locality of origin of the strain (e.g. Eloka), the year of 
publication (e.g. 1979),  the biovar (e.g. B. abortus 1) and the number of isolates 
identified (eg. n=2). 
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The presence of Brucella in cattle being confirmed again almost twenty years after the 
first isolates, it confirms the existence and the persistence of a potential risk for the human 
population. Indeed, the risk cannot be precluded in the West African epidemiological context 
where i) close contact may occur between animals and people, particularily in urban and peri-
urban areas; ii) hygienic conditions are usually poor; iii) customs often favour consumption 
of raw milk, and iv) where no prevention and/or control strategies are sustainabily 
implemented. However, more data on human cases are needed to clearly establish the public 
health importance of the disease. As a starting point, seropositivity among slaughterhouse 
workers and other high-risk professionals might be investigated combined with isolation and 
characterization of Brucella. Reporting of the disease in human could also be improved by 
considering brucellosis as part of the differential diagnosis for patients with fever of unknown 
origin (FUO), fever being the most common clinical features in human (Franco et al., 2007).  
The comprehensive review of prevailing strains in the field also reveals the frequent isolation 
of strains of B. abortus with unusual characteristics in this sub-region of West Africa (in 
Senegal, Togo, Niger, The Gambia as well as in Ivory Coast). With conventional typing 
methods, the differences were not always clear for some of these strains, complicating their 
classification. The existence of these strains should be considered when typing field strains of 
Brucella in West Africa. This may also justify the need for more typing in the region and, 
wherever possible, for the application of more accurate discriminative methods (e.g. MLVA) 
in addition to conventional biotyping (Bankole et al., 2010; Sanogo et al., 2013a, Dean et al., 
2014). In Ivory Coast the difference between biovar 6 and 3 being not always clear, the 
availability of more discriminative methods would have been very useful. Identification and 
typing of Brucella strains must continue and be maintained. This type of research will also 
provide information on possible sources of human infection and on transmission pathways 
between animals and humans. This is a step needed for an appropriate prevention and control 
of brucellosis (Adone and Pasquali, 2013). Additionally, the introduction of more advanced 
methods for identification and typing of Brucella such as the Variable number tandem repeat 
(VNTR) typing or Multilocus Sequence Analysis (MLSA) should be considered in a regional 
or continental control strategy for cost-effectiveness. 
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8.1.2. True prevalence, sensitivity and specificity of serological assays for the 
diagnostic of brucellosis in Ivory Coast 
Information on the prevailing field strains of Brucella is also important to select the 
adequate serological diagnosis tests. In addition to information on the actual presence of the 
disease, serological diagnostic tests are essential to discriminate the status of individuals or 
group of individuals. Tests are useful for understanding the disease epidemiology and for 
informing on possible preventive and control programs. However, none of the tests detecting 
Brucella is perfect and sources of interferences exist with many others Gram negative 
bacteria due to the presence of similarities with immunodominant antigen used (Saegerman et 
al., 2004). Vaccination with strain S19 is also responsible for serological cross-reaction 
(Corbel, 2006). Therefore, these possible sources of interferences should be taken into 
account while interpreting serological results (Robinson, 2003). In the epidemiological 
context of Ivory Coast, vaccination is no more officially practiced since 1992 and no official 
control program exists so far, excluding therefore interference due to vaccination.  
As described in our literature review, most serological assays commonly used for the 
diagnosis of bovine brucellosis use the B. abortus 1 antigen derived from the strain 
Weybridge 99, epitope A. As a consequence, the performance of assays will also depend on 
the prevailing field strains in the epidemiological context in which they are applied. The 
performance of two serological tests commonly used for the diagnostic of brucellosis and 
also prescribed for trade by OIE (Nielsen, 2002; Saegerman et al., 2004; OIE, 2009; Godfroid 
et al., 2010; Sanogo et al., 2013a) were assessed in the epidemiological context of Ivory 
Coast. Ideally, the sensitivity and the specificity of a diagnostic test require knowledge on the 
true disease status of the population in which the test is applied. This implies, in turn, the 
availability of a “gold standard reference test” which is absent. Therefore, sensitivity and 
specificity of Rose Bengal Test and indirect Enzyme Linked Immunosorbent Assay were 
determined in our study using a Bayesian approach (Chapter 5). By offering the possibility 
to combine prior or expert knowledge on parameters and actual field data in the same model, 
the Bayesian approach helps to have more accurate and reliable estimates in absence of a 
gold standard. However, accuracy and validity of Bayesian estimates depend on the 
availability and the quality of prior information included in the estimation and on the validity 
of the protocol (e.g. conditional dependence between tests). In developing countries like 
Ivory Coast where good priors are lacking, their influence has to be checked using a set of 
prior distributions, as done in this work. An accurate estimation also requires a representative 
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sample of the target population including all age categories and, ideally the different stages of 
the disease. In our work, two datasets were combined to improve the representativeness. 
From a geographical point of view, the representativeness of the aggregated sample for the 
whole country might be questionable, since only serum collected in cattle herds from the 
Southern and central regions of the country was used for estimation. However, no association 
was demonstrated between the origin of sera and the serostatus of cattle included. Moreover, 
the combined sample included sedentary as well as extensively managed herds with different 
herd size, age and sex categories, and all types of breed of the country. This allows us to 
reasonably consider that the aggregate sample was matching the characteristics of the overall 
cattle population of Ivory Coast. The provided estimates can therefore serve as prior 
knowledge for future Bayesian estimation of test characteristics and of disease true 
prevalence in similar conditions in Ivory Coast.  
In addition to the provision of estimates of test characteristics, the Bayesian approach 
also delivered an updated estimation on the true disease prevalence in the sample population. 
Except the latest studies, most of the previous reports on the prevalence of brucellosis in 
Ivory Coast, reported only apparent prevalences. Since the prevalence is essential to appraise 
the impact of a disease in a population of interest, the estimation of the disease true 
prevalence is of key importance to prevent a biased estimation of disease burden (Dohoo et 
al., 2003; Speybroeck et al., 2012a). Therefore, the usefulness of methodological options 
such as the Bayesian approach is obvious. Using a combination of three serological tests, the 
Bayesian estimates in the central savannah-forest area of the country was 8.8% (credibility 
interval: 5.0-16.4) (Chapter 6). An overall estimate of the true prevalence of brucellosis 
using aggregated samples from cattle herds from both central and southern parts of the 
country was 4.6% (credibility interval: 0.6-9.5) (Chapter 5). Even if the sampling strategy 
for the two datasets used in these estimations needs to be taken into consideration, these 
results provide useful indications on the presence of Brucella and the spread of the disease in 
cattle, justifying the attention that should be given to brucellosis in Ivory Coast. In addition to 
the sampling bias, the accuracy of the first estimates (Chapter 6) is more questionable since 
the correlation between the tests on seropositive and seronegative cattle was not taken into 
account in the modeling process. Indeed, the combination of diagnostic tests targeting a 
similar biological phenomenon -such as immunoglobulins- may result in dependence or 
correlation between them (Gardner et al., 2000). According to the conjugate used, conditional 
dependence had to be considered between RBT, detecting the presence of Immunoglobulins 
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(Ig) IgG1 and iELISA, targeting IgG1 and/or IgG2 (Nielsen, 2002; Saegerman et al., 2004 and 
2010; Sanogo et al., 2013a). Moreover, the sensitivity analysis to assess the consistency of 
estimates was not performed as recommended (Branscum et al., 2005). Therefore, it appears 
that an appropriate sampling strategy should be designed at the beginning of any study 
aiming to estimate true prevalence or test characteristics using a Bayesian approach and the 
dependence between tests and the implementation of a sensitivity analysis on estimates are 
crucial to facilitate extrapolation of estimates. 
Since the performance of RBT and iELISA was evaluated in the Ivorian context, they can be 
used to support decision making for control and serosurveillance. Different testing strategies 
can be considered. Following a serial interpretation, RBT positive results have to be 
confirmed by iELISA while following a parallel interpretation the testing scheme will be 
expected to detect both acute and chronic infection (Saegerman et al., 2004; Godfroid et al., 
2013). As demonstrated in this research, the iELISA might also be implemented on its own. 
However, a combination with other serological tests as the RBT would be a more appropriate 
strategy. Since most of the serological tests such as RBT and iELISA do not inform on the 
source of infection, the capabilities of veterinary services for the detection of Brucella need 
to be improved. In the short-term, identification methods such as the Matrix-assisted laser 
desorption/ionization time-offlight mass spectrometry (MALDI-TOF-MS) might be 
introduced to identify Brucella at a genus level at the central laboratory, with an enhancement 
of biosecurity and biosafety measures.  
8.1.3. Risk factors associated to the seropositivity of brucellosis in cattle from 
Ivory Coast  
Many factors including the density of the animal population, herd size, breed, type of 
production (dairy or beef), type of husbandry system and environmental factors are thought to 
be associated with brucellosis. In this research, potential risk factors associated to 
seropositivity in cattle populations in Ivory Coast were also examined (Chapter 7). This is 
the first work reporting information on risk factors associated with brucellosis in Ivory Coast. 
Serological data obtained through a survey in the central savannah-forest area of the country 
were analyzed using a logistic regression. Age of animals and herd size were identified as 
risk factors associated with seropositivity of brucellosis in Ivory Coast. Specifically, animals 
above 5 years of age were estimated to be almost 3 times more likely infected than 3 years 
old cattle. A similar ratio was observed for cattle herds with more than 100 heads compared 
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to those with less than 50 heads. This information can be used for increasing farmers 
awareness and regulating herd management practices in order to decrease the seroprevalence 
of Brucella in animals and consequently prevent human infections. Indeed, education on risk 
factors associated with brucellosis is essential to limit the spread of the disease. 
These results were obtained using only data collected in the central soudano-guinean area but 
could be reasonably extrapolated to the whole country, as there is currently no control 
strategy against brucellosis at all. In addition to the identification of risk factors at animal 
level, which was the focus of this work, environmental risk factors need to be investigated as 
they may also provide information to elaborate prevention and control strategy. The results 
are in line with the findings of Akakpo and Bornarel (1987) who identified the age of animal, 
the type of breed and the climate as risk factors for brucellosis. It was also demonstrated that 
the effect of crowd (e.g. large herd size) together with lower genetic diversity may favor 
transmission and select fast replicating organisms with major zoonotic potential as Brucella 
(McDaniel et al., 2013). Boukary et al. (2013) recently also identified the age of animal as 
individual risk factor in traditional cattle farms from Niger. Together with the acquired 
knowledge on the prevailing field strains of Brucella (Chapter 4 and 5), the data gained on 
diagnostic tests performance (Chapter 5), disease true prevalence (Chapter 5), and risk 
factors (Chapter 7) are helpful to develop and implement preventive and control measures. 
8.2. Conclusions, implications and perspectives 
The development of livestock and the improvement of their health status are an 
essential part of a pro-poor enhanced food security strategy for the benefit of vulnerable 
populations in developing countries such as Ivory Coast. This urges to deal with pathologic 
constrains like brucellosis.  
Bovine brucellosis is endemic in many sub-Saharan African countries including Ivory 
Coast. Its impact on animal production and zoonotic potential are currently well known and 
the benefits of controlling it was also strongly demonstrated in cattle. However, the disease is 
still considered as a non-priority disease, i.e. suffering from insufficient knowledge on its 
epidemiology and public health importance. Therefore, gaining more and accurate knowledge 
on the epidemiology of brucellosis is required to determine the actual impact of the disease. 
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It will help to convince the decision makers to implement appropriate and sustainable 
disease preventive and control measures at national level but also at regional level 
considering the frequent transboundary herd movements (transhumance). 
The current research confirms the presence of bovine brucellosis in Ivory Coast and 
contributes to the knowledge of the epidemiology of the disease. This research investigates 
prevailing field strains of Brucella in cattle in Ivory Coast but also provides information at 
West African scale. Biovar 3 of Brucella abortus was identified for the first time in Ivory 
Coast in cattle in this research. Additionally, the performances of Rose Bengal test and 
iELISA were assessed in the Ivorian epidemiological context, since those tests are of key 
importance for investigating the epidemiology of the disease as well for planning prevention 
and control measures. Finally, Estimates of the true prevalence of the disease are now 
available and some risk factors associated with brucellosis in the country identified for the 
first time.  
Initially, this research intended to cover the different agro-ecological areas of the 
country including the northern part where the density of cattle population and the presence of 
transhumant herds are expected to influence the disease epidemiology. Finally, only the 
southern Guinean and the central Soudano-guinean aeras were covered. This was mainly due 
to the socio-political context prevailing in the country at the moment of the field study. Data 
obtained in the accessible areas where combined with previous data collected in the same 
aeras for true prevalence estimation and for diagnostic performance assessement. The 
rationale supporting this approach and the consequences on the interpretation of the findings 
are discussed in Chapter 5 and 6. The contribution on prevailing strains of Brucella in cattle 
was done by combining a prospective and a retrospective approach. In the prospective 
approach, only one isolate was obtained, which was very few despite the added value that it 
provides. However, this stresses the need for more investigation in field strains of Brucella in 
cattle. Even if hygroma fluid was demonstrated to be a useful sample for strain identification 
(Sanogo et al., 2013a), other samples such as abortive materials and secretions should be 
considered. By considering exchanges and movements of cattle within Ivory Coast but also 
between countries of West Africa, the review provided a more extended picture on the 
prevailing strains.  
Despite its limitations, our research contributes largely to a better knowledge of the 
epidemiology of brucellosis in Ivory Coast and in West Africa. Additional investigations are 
needed to obtain a global picture and a reliable understanding of the disease epidemiology. 
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This is crucial to provide useful evidences to advocate among decision makers for adequate 
preventive and control measures against brucellosis. It will therefore be crucial to investigate 
the frequency and the distribution of the disease and the associated risk factors in other 
regions of Ivory Coast, especially in the northern part where the density of cattle population 
is higher and where animal movements (transhumance) might influence the disease 
epidemiology. Compared to the southern and central areas, the distribution and the frequency 
of the disease in the North might be higher. Information about the presence of Brucella in the 
different livestock breeding areas and systems of the country are essential to implement 
effective and appropriate prevention and control measures. The role of small ruminants as 
source of infection for cattle and for human also needs to be addressed. This is important to 
assess the risk of human brucellosis within the country. Furthermore, other susceptible 
livestock and wildlife species need to be studied in order to obtain a more extended picture of 
the disease epidemiology at national and at regional level.  
 
In addition to the need of future research for a better understanding of the epidemiology 
of bovine brucellosis in Ivory Coast as well as in West Africa, this research inspired some 
points, which need to be considered for an efficient and sustainable prevention and control of 
brucellosis as well as other (zoonotic) diseases: 
 The diagnostic and surveillance capacities of veterinary services need to be 
strengthened to provide valuable epidemiological information, especially on 
prevailing strains of Brucella. Hence, improvement of veterinary diagnostic 
laboratory capabilities, veterinary surveillance and quality and organization of 
veterinary services are fundamental to provide reliable data, gain of confidence in the 
veterinary services and disease surveillance, and to ensure the efficiency of the 
preventive and control programs of brucellosis as well as other zoonoses. So far, RBT 
is routinely used for screening in Ivory Coast. Additional tests such as indirect or 
competitive ELISA and FPA also need to be assessed and established as confirmatory 
tests in the central veterinary laboratory in Ivory Coast. There is also a need to 
upgrade the laboratory facilities and equipements for safe management of samples 
possibly contaminated by level 3 pathogens as Brucella. In addition, a comprehensive 
training on biosafety and biosecurity measures and procedures is also important for 
laboratory workers, for scientists and for all the persons at risk or working with such 
hazardous pathogens.  
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 Based on updated information provided on the epidemiological status of bovine 
brucellosis, a pilot control project covering the savannah-forest sedentary cattle herds 
and dairy herds in Ivory Coast can be suggested to lower the prevalence (down to 
2%). This strategy might include prevention and control measures such as 
surveillance of dairy herds at national scale through milk testing (at least twice per 
year), annual vaccination of young calves, seromonitoring of herds (with RBT and 
iELISA or FPA or competitive ELISA), elimination of infected adult animals from 
herd and serological control before introduction in the herd. Campaigns of public 
awareness and education aiming to prevent and reduce risks of transmission from 
animals to humans are also imperative to sensitize on safe herd management practices 
and to improve notification of cases of abortion and hygroma. Consideration of the 
risk factors identified so far in the Ivorian context is helpful to prevent the spread of 
the disease within cattle population and from cattle to human. This control strategy 
will be progressively expanded to other livestock breeding areas of the country, but 
need to be backed by sufficient and updated knowledge on the disease epidemiology 
(e.g., true prevalence), in line the stepwise progressive approach proposed by FAO 
(FAO, 2013).  
 The maintenance and the improvement of animal health depend not only on financial 
issues but also on capacity, quality, competence, transparency, expertise and 
organization of veterinary services. Hence, the results and recommendations of the 
OIE Performance of Veterinary Services (PVS)
8
 assessement are fundamental and 
need to be considered. Especially, the adequate coverage of the territory with 
operational veterinary services (both public and private) is required in Ivory Coast 
after the socio-political crisis of the last ten years. This is of key importance to set up 
a functional and sustainable surveillance network, for reporting animal diseases and 
                                                 
 
8 The OIE Tool for the Evaluation of Performance of Veterinary Services (OIE PVS Tool) is an 
evaluation tools, developed initially in collaboration with the Inter-American Institute for 
Cooperation on Agriculture (IICA) and refined by the OIE, aiming to strengthen the veterinary 
Services by helping them comply with OIE international standards for quality. It is designed to assist 
VS to establish their current level of performance, to identify gaps and weaknesses in their ability to 
comply with OIE international standards, to form a shared vision with stakeholders (including the 
private sector) and to establish priorities and carry out strategic initiatives for improvement. More 
information are available on: http://www.oie.int/en/support-to-oie-members/pvs-evaluations/oie-pvs-
tool/ 
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disease related events and for designing appropriate and efficient prevention and 
control measures. In addition to the effective implication and cooperation with 
community members (e.g., head of community, paraveterinarians, members of 
cooperatives, animal owners), the introduction of new tools such as internet and 
mobile technology might contribute to improve the efficiency of the epidemiological 
surveillance network especially regarding field data collection, notification of cases of 
abortion and transmission of reports. The commitment of the government is also 
essential to guarantee the sustainability of such a system (Ouagal et al., 2008; Ouagal 
et al., 2012). 
 The presence of Brucella in most of the West African countries, the existence of cattle 
movement between countries and the limited resources allocated for disease control in 
most of African countries are in favour of the creation of a collaborative regional 
prevention and control strategy to contain brucellosis infection. Such a strategy should 
adopt the One Health or the Ecohealth principle (Zinsstag, 2013). The approach 
should take into account the particular ecosystem of West African countries and 
should ensure more cooperation, and exchange of information and resources between 
public health and veterinary authorities not only at national level but also at regional 
level. The One Health approach implies an integrated approach involving both human 
health and veterinary services for the surveillance of zoonotic diseases such as 
brucellosis. This approach allows to better understand the epidemiology of zoonotic 
diseases and induces a more efficient utilization of the limited resources (Saegerman 
et al., 2010; Dean et al., 2012). Creation of zoonotic disease units should also be 
promoted to formalize the above-mentioned intersectoral collaboration. A regulatory 
framework is also needed for a better coordination of control activities in the field 
within and between countries. In the same spirit, collaboration between researchers, 
public health and veterinary actors of Ivory Coast and neighbouring countries need to 
be established and strengthened. The establishment of a reference laboratory at 
regional level needs to be considered. Finally, the commitment of national authorities 
and the political support and leadership of regional institutions such as the Ecomonic 
Community of West African States (ECOWAS) represent a key requirement, 
beneficial for the sustainability and the development of livestock in the region.  
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Despite the numerous priorities, more attention and consideration needs to be given to 
brucellosis as well as other endemic neglected zoonotic diseases, especially in low-income 
country as Ivory Coast. This is essential to foresee a sustainable development of livestock, to 
cover the needs of populations in terms of animal protein and to contribute to poverty 
alleviation.  
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Annex 1: Map showing the western part of Africa and the neighbour countries of Ivory 
Coast 
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Annex 2: Differential characteristics of biovars of Brucella species (from OIE, 2009) 
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Annex 3 : A cow with a carpal hygroma 
 
(Credit picture: M. Sanogo) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
